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Twenty years from now 
you will be more disappointed 
by the things you didn’t do 
than by the ones you did do. 
So throw of the bowlines. 
Sail away from safe harbour. 
Catch the trade wind in your sails. 
Explore. 
Dream. 
Discover. 
 
Mark Twain 
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General introduction and outline of the thesis 
Anorectal diseases 
Epidemiology 
Faecal incontinence is defined as the involuntary passage of feces through 
the anal canal 1. It affects individuals of all ages and is associated with a 
great impairment of quality of life, causing social isolation because of 
embarrassment, humiliation and anxiety of unexpected episodes of faecal 
incontinence.  
The exact incidence of faecal incontinence is hard to determine. Many 
studies mention prevalence of faecal incontinence from 11 to 15% of the 
population, with female predominance 2. The exact numbers in the 
Netherlands are unknown. The prevalence increases steadily with age, from 
4% for incontinence in those between 40 and 49 years old, to 17-66% in 
patients above 80 years 3. The prevalence of faecal incontinence in nursing 
home residents is even higher, up to 50% 3.  
 
Physiology 
Maintenance of continence depends upon multiple anatomic, physiologic 
factors and on a sophisticated interaction between the central and 
peripheral nervous system and the muscular system. Anal sphincter complex 
consists of several pelvic floor muscles. The internal anal sphincter is a 
continuation of the circular smooth muscle of the rectum and is innervated 
by sympathetic and parasympathetic nerve fibers. The internal anal 
sphincter is the main contributer to the anal basal pressure 4. Increasing 
rectal volume causes relaxation of the internal sphincter. The external anal 
sphincter consists of striated muscle fibers and is innervated by the 
pudendal nerve. This sphincter can be contracted voluntarily or by reflex 
when intra-abdominal pressure increases.4 Defecation is initiated by m. 
puborectalis relaxation and propulsive contraction in the rectum. This elicits 
a simultaneous relaxation of the anal canal sphincters and pelvic floor. 
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Increasing intra-abdominal pressure induces relaxation of the external 
sphincter 4.   
 
Etiology 
Although, it seems often a problem of elderly people, faecal incontinence is 
still underestimated in the younger population. Childbirth, especially with 
difficult vaginal delivery is the most prominent factor. However, several 
factors contribute to incontinence. In women after delivery both a post-
rupture sphincter defect and pudendal neuropathy following excessive 
straining can occur. The studies using 3-dimentional imaging modalities 
report an incidence of injury in 11% 5. Other risk factors are anorectal 
surgery, trauma from impairment or pelvic fracture, immobility, dementia, 
diabetes, multiple sclerosis, Parkinson’s disease, stroke, spinal cord injury and 
some congenital abnormalities, such as imperforate anus 6.  
In many patients with diarrhea the cause is multifactorial and for this reason 
it is difficult to identify.  
 
Diagnostic procedures 
A comprehensive medical history and a thorough physical examination are 
essential for right diagnosis. It is important to determine the impact of the 
faecal incontinence on the patient and their every day live. The Vaizey 
score containing specific incontinence items that can be helpful to 
establish severity of incontinence for study purpose, where besides the 
frequency and consistency of the bowel movement, also the social impact 
and use of napkins are included 7.  Especially rectal examination gives 
accurate information about structural disorders.  
Anorectal function test consists of anal endosonography, anal manometry 
and rectal compliance measurement.  
Anal endosonography is widely available and the least expensive 
technique to visualize possible defects or atrophy of the anal sphincter 
complex. It has a reasonable learning curve, and is easily reproducible, 
especially with the 3D modus.  The internal anal sphincter is visible as an 
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hypo-echoic layer, and the external anal sphincter exhibits a mixed 
echogenic pattern. In women, in whom it is not possible to obtain good 
rectal image, vaginal endosonography can give additional information.8 
Three dimensional imaging is a new modality which offers view from all 
aspects. This method can be used to detect external anal sphincter atrophy 
and defects 9. 
Anal manometry establishes anal pressures at rest, during squeezing and 
during straining. The rage of normal values is large, due to the gender and 
age. Patients with faecal incontinence have lower pressures than healthy 
controls, but there is considerable overlap of values between the two 
groups. Therefore, anal manometry has limited diagnostic value. It could be 
valuable in the follow up of patients who receive biofeedback or in 
evaluation of surgical treatment but not in making treatment decisions 10. 
Rectal compliance measures sensitivity and the volume of the rectum. 
There is also large range of normal values, with overlap with patients with 
faecal incontinence. Again, this test has limited clinical value.  
Merely the extreme volumes have direct clinical impact. A rectal capacity 
between 60 and 100ml will lead to faecal incontinence in 50% and < 60ml 
will predict incontinence in 100% of patients 11. 
 
In chapter 2 we determine the indicated referrals for patients with anorectal 
symptoms for anorectal function evaluation, which lead to relevant findings 
or change of the therapy. In addition we have studied an effect of advice 
and perceived discomfort for the patients during anorectal function 
evaluation. Besides the tests mentioned above, other tests were evaluated. 
Defecography involves imaging of the rectum with contrast material and 
observation of the process, rate and completeness of rectal evaluation. It is 
performed only on strict indications.  
Endoanal Magnetic Resonance Imaging (MRI) like anal endosonography 
can give a good impression of the anatomy of the anus and pelvic floor. 
Sphincter defect can also be demonstrated. MRI is preferred in patients with 
high anorectal malformation, since anorectal endosonography does not 
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provide adequate imaging of the pelvic floor above the level of the 
puborectal muscle 12. 
Neurophysiological testing includes conventional electromyography, single 
fiber electromyography (EMG) and the assessment of pudendal nerve 
terminal motor latency (PNTML). EMG can demonstrate functional muscle 
tissue in a scarred anus, and can give a good impression of the myogenic 
component of the sphincter. The fiber density of the external anal sphincter 
can be measured 13. PNTML gives an impression of the innervation of the 
external anal sphincter and pelvic floor. Although, this tests have increased 
insight in the pathogenesis of faecal incontinence, their clinical relevance is 
small.   
 
Therapy work-up 
The first step in treatment of faecal incontinence is regulating defecation 
with fiber enriched diet and fiber supplementation.  
The next available step is careful physiotherapy or biofeedback of the 
pelvic floor. It is safe and non-invasive procedure, which should be always 
be tried before referral for further diagnostic and therapy 14. Patients are 
trained to increase the anal sphincter contractile capacity in response to 
rectal distension. This therapy may be more effective in patients with urge 
incontinence than in patients with passive incontinence 4. However, the 
additional tests are not helpful in prediction of the long-term outcome of 
biofeedback 15. 
When conservative treatment is unsuccessful, surgical options are possible in 
certain patients. Patients with sphincter defect can be offered a sphincter 
repair. However, only few patients have a sphincter defect suitable for 
repair. Other forms of  surgical therapy, as dynamic gracilis plasty, 
neuromodulation or artificial bowel sphincter are available in few centers. 
Those methods of treatment carry certain side effects, and give only 
moderate improvement 16.  
In patients without chronic diarrhea, in whom physiotherapy and surgery is 
not possible or have failed, treatment with cholestyramine or (intermittent) 
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loperamide may be a reasonable option. Sometimes enemas and rectal 
cleansing in the morning can diminished the chance of faecal 
incontinence. Anal plugs are also a therapeutic option for faecal 
incontinence, especially in children 17. Both the diagnostic and therapeutic 
advices were evaluated. 
 
In chapter 3, the new therapeutic option, temperature-controlled 
radiofrequency energy (SECCA) is evaluated. This procedure has shown a 
persisting good results. It is safe outpatient procedure for patients in whom 
diet regulation and physiotherapy have failed and sphincteroplasty is not 
indicated. This treatment give few generally acceptable side effects. This 
promising procedure has to be further evaluated in randomized trials 18.  
 
Colorectal diseases 
Irritable bowel syndrome (IBS) is a common functional bowel disorder in 
which abdominal pain or discomfort is associated with defecation or 
change in bowel habit and with features of disordered defecation. 
Throughout the world, about 10 % of adults have symptoms consistent with 
IBS, and most studies find a female predominance 19. In Dutch general 
practitioners practice the prevalence of IBS is round 2%, but a mere 22-28% 
of the patients with IBS symptoms ask for help a doctor.  
The pathophysiology of IBS has been thought to involve an interplay 
between psychosocial stressors and abnormalities in gut motility and 
visceral sensation. Different motility abnormalities have been described. IBS 
occurs usually in three subtypes; with diarrhea, constipation or mixed type. 
Additionally, disorders of evacuation, as seen with puborectalis dysfunction 
or a rectocele may play a role. Visceral hypersensitivity has long been 
accepted as an important feature in a subset of IBS patients. The enteric 
nervous system, which regulates motor, secretory and sensory functions 
through an extensive neural network in the gastrointestinal tract plays also a 
role in pathophysiology of IBS. There is currently much interest in the role of 
inflammatory cells or mediators in at least some types of IBS. Postinfectious 
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gastrointestinal immune activation, small intestinal bacterial overgrowth 
and celiac disease-mediated inflammation have also been postulated to 
play a role in development of IBS symptoms 20. Diagnosis is based on criteria 
agreed at a conference in Rome 19.  
IBS is a heterogeneous condition, with wide spectrum of symptoms. 
Sometime diagnosis is not easy, especially when more different conditions 
coexist. It is reported, that the worsening of IBS symptoms during 
menstruation in women with endometriosis may obscure the diagnosis of  
IBS 21. Endometriosis is a chronic debilitating gynaecological condition 
which often presents with symptoms that may be similar to those of 
gastrointestinal disorders. It is characterized by the presence and 
proliferation of endometrial tissue outside the uterine cavity, which occurs in 
approximately 10% of women of reproductive age. The prevalence of IBS is 
approximately 32% in women with endometriosis without bowel lesions 22. 
Therefore, wider gastroenterological evaluation is needed in overlapping 
symptoms so that neither accurate diagnosis is missed nor right treatment is 
delayed in patients with endometriosis and IBS. Successful management of 
IBS combines individualizing treatment of predominant symptoms and 
conferring insight on how symptoms may related to emotional stress. 
Evidence for efficacy of therapies is complicated by high placebo effect 
and is up to 40-50% in IBS trails. Treatment of bowel dysfunction is focused 
on accelerating or slowing transit as required, where fiber supplementation, 
antidiarrheal  and non-stimulant osmotic laxatives are used. Antidepressants 
used is low doses have a visceral analgesic effect, and antispasmodics can 
be useful for abdominal pain. The complementary therapies can also give 
some support in the treatment of IBS, as biofeedback may help patients 
gain control over their symptoms, or hypnotherapy and meditation cause 
focused relaxation 20.  
The study presented in chapter 4 shows importance of multidisciplinary 
diagnostic of such complicated conditions as irritable bowel syndrome. 
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Diverticulair disease is one of the most common pathologies affecting the 
colon. During the last century diverticulosis has become more frequent, 
mainly in industrialized Western countries. Disease is present in up to 10% of 
individuals under the age of 40, and increases up to 40-70% of those above 
70 years of age. Westernized lifestyle predominate for diverticula located in 
the left colon, for 95% in the sigmoid. In Eastern populations prevalence 
rates are 1-4%, and a right colon predominance is observed 23. There is no 
difference in prevalence of the disease in men and women.  
The development of colonic diverticula is probably determined by two 
factors: a weak colonic wall and increased intraluminal pressure.  
Increasing incidence in the developed countries suggests that 
environmental and lifestyle factors play an important role in the 
pathogenesis of diverticulair disease.  
A majority of patients with diverticulosis never develop any symptoms. 
Approximately 15% to 25% of patients with diverticulosis will develop 
diverticulitis, 5% to 15%  will develop divertlcular bleeding. Among patients 
with diverticulitis 25% will be complicated by abcess formation, a fistula, 
intestinal obstruction, or a perforation 23. Chapter 5 is an extensive review of 
this interesting disease. 
 
The relation between diverticulosis and colorectal cancer is also suggested. 
Both diseases are more frequent in developed countries and are age-
dependent, as both are uncommon in those under the age of 40. 
Colorectal cancer is a leading cause of cancer mortality in the Western 
world, with more than 1,000,000 new cases per year and with 500,000 
deaths per year worldwide 24. In the Netherlands, colorectal cancer is 
diagnosed in about 10,000 patients each year and causes 4,400 deaths per 
year 25. A possible explanation for the association between the two diseases 
is that they share similar risk factors. They have the same pathogenic 
factors, like the western low fiber diet and rich in saturated fat 26. A causal 
relationship between the two diseases has also been suggested.  
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In chapter 6 we studied transversally the possible risk for colorectal 
neoplasia or polyps in patients with diverticulosis and diverticulitis. The study 
presented in chapter 7 is related to chapter 6. The aim of this study was to 
assess the relationship between diverticulitis and the development of CRC 
and colorectal adenomas in a longitudinal study. 
 
Patients compliance 
Elective colonoscopy is very important in screening and surveillance 
programs for patients with colorectal disease. Especially in elderly patients, 
colonoscopy is recommended to exclude malignancy. Inadequate 
preparation can result in missed pathology, can prolong time of insertion 
and increase the risk of complications 27. Therefore, effective, good 
cleansing, well tolerated by patients is mandatory for good quality and 
safety of the colonoscopy.  
In chapter 8 the importance of a good bowel preparation for appropriate 
and safe diagnostic is evaluated.  
In chapter 9 the taste of two polyethylene glycol preparations for chronic 
constipation was compared.  
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Abstract 
Aim  
To determine the indicated referrals to a tertiary centre for patients with 
anorectal symptoms, the effect of the advised treatment and the 
discomfort of the tests. 
Methods  
In a retrospective study patients referred for anorectal function evaluation 
(AFE) between May 2004 and October 2006 were sent a questionnaire, as 
well as the doctors who referred them.  
AFE consisted of anal manometry, rectal compliance measurement and 
anal endosonography. An indicated referral was defined as needing AFE to 
establish a diagnosis with clinical consequence (faecal incontinence 
without diarrhea, 3rd degree anal sphincter rupture, congenital anorectal 
disorder, inflammatory bowel disease with anorectal complaints and 
preoperative in patients for re-anastomosis or enterostoma, anal fissure, 
fistula or constipation). Anal ultrasound is always indicated in patients with 
fistula, anal manometry and rectal compliance when impaired continence 
reserve is suspected. The therapeutic effect was noted as improvement, no 
improvement but reassurance, and deterioration. 
Results   
From the 216 patients referred, 167 (78%) returned the questionnaire. The 
referrals were indicated in 65%. Of these, 80% followed the proposed 
advice. Improvement was achieved in 35% and a reassurance in 57% of the 
patients, no difference existed between patient groups. On a VAS scale (1 
to 10) symptoms improved from 4.0 to 7.2. Most patients reported no or little 
discomfort with AFE.  
Conclusion  
Referral for AFE was indicated in 65%. Beneficial effect was seen in 92%: 35% 
improved and 57% was reassured. Advice was followed in 80%. Better 
instruction about indication for AFE referral is warranted.  
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INTRODUCTION 
Anorectal function evaluation (AFE) consists of several tests. Institutions differ 
in their selection of tests 1. At our tertiary centre, anal manometry, rectal 
compliance measurement and anorectal endosonography are performed 
as part of our standard procedure 2. Defecography and colon transit time 
are performed on strict indications. Neurophysiological tests of the pelvic floor 
are performed only for research purposes. Anal manometry establishes anal 
pressures while rectal compliance measures sensitivity and the volume of the 
rectum. Anal endosonography visualizes possible defects or atrophy of the 
anal sphincter complex. AFE is often requested in patients with anorectal 
symptoms, e.g. faecal incontinence, anal soiling, fistulas, anorectal tumours, 
anal pain, constipation e.g. AFE is available in a limited number of hospitals, 
mainly academic centres and some large peripheral clinics.   
A clinical referral (no research purposes) is indicated when disease can be 
demonstrated or excluded on the basic of AFE and when it has further 
therapeutical consequences. Which patients benefit most from anorectal 
function tests (by reduction of symptoms or reassurance) is unclear. 
Literature concerning this issue is scarce. Most studies that mention 
anorectal function tests in relation to anorectal pathology limit themselves 
to pre- and post-treatment results. Therefore it often remains unclear 
whether AFE leads to relevant findings or subsequent change of therapy 1-10. 
A large multi centre Dutch study referred to the value of AFE for outcome of 
physiotherapy in patients with faecal incontinence 1. One conclusion was 
that AFE had no predictive value for outcome of physiotherapy. Further, 
referral for AFE largely depended on availability of these tests in the referring 
hospital.  
The aim of this study was to determine the indicated referrals to our tertiary 
center for patients with anorectal symptoms, the effect of the advices on 
their complaints and the the perceived discomfort for the patients during 
AFE.
                                                                        
  24  
MATERIALS AND METHODS  
Patients 
All patients who were first clinical referrals for AFE between May 2004 and 
October 2006 were selected from our database. The database contained 
the complete medical history and extensive data of anorectal symptoms 
and anorectal test results. Deceased patients were excluded. The patients 
were sent a questionnaire. Additional data about follow-up in the 
outpatient clinic, hospital admittance, diagnostic and therapeutic 
procedures performed in our hospital could be retrieved from the 
(electronic) patient hospital files. 
The Medical Ethical Commission of the VU University Medical Centre 
granted permission. 
The referring doctors 
The doctors who referred patients in the period 2004-2006 were also sent a 
questionnaire.  
Anorectal function evaluation (AFE) 
This consisted of anal manometry, rectal compliance measurement and 
anorectal endosonography according to our methods previously  
described 11. 
Indicated referral 
A referral is indicated when disease can be demonstrated or excluded on 
the basic of AFE and when it has further therapeutical consequences. These 
are patients with faecal incontinence without diarrhea, 3rd degree sphincter 
rupture with or without faecal incontinence, congenital disorders, patients 
with inflammatory bowel disease with anorectal complaints and 
preoperative in patients for re-anastomosis or enterostoma, anal fissure or 
constipation. In patients with fistula an ultrasound is always indicated but 
anal manometry and rectal compliance measurement only on indication 
regarding faecal incontinence. Test results in all these patients influence 
management. In patients with constipation AFE was considered indicated 
in suspected Hirschsprungs’ disease and surgery. AFE was not considered 
indicated in patients with fissures treated conservatively, soiling (defined as 
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anal discharge without overt faecal incontinence), anal pain and 
hemorrhoids, since results do not change management. 
Questionnaires 
The questionnaire for patients 2 contained questions about the actual 
received therapy, changes in their symptoms by the received treatment, 
stated in a Visual Analogue Score (VAS) (score 1-10, 1=very bad, 10=very 
good) and also stated as (1) improved, (2) no change but reassurance or 
acceptance of situation without further need for seeking other medical 
advice and (3) worse and/or no reassurance. Discomfort and pain during 
the examination was scored with VAS (score 1-10, 1=very uncomfortable/ 
painful, 10=no discomfort/pain).  
The questionnaire for the referring doctor2 consisted of questions about 
implementing the advice (yes, no), the quality of the advice (good, neutral, 
poor) and the willingness to refer again (yes, no).  
Treatment advice strategy 
The patients with symptoms of faecal incontinence were divided into 5 
diagnostic subtypes: incontinence due to a sphincter defect, neurogenic 
incontinence, combined incontinence (sphincter defect and neurogenic), 
incontinence due to small rectal capacity and incontinence due to 
diarrhea. 
Patients with incontinence due to diarrhea were advised to have the cause 
of their diarrhea sorted out by the referring doctor. 
All patients with faecal incontinence were prescribed fibres and 
physiotherapy. When unsuccessful additional therapy was advised 
depending of the cause.  Patients with a sphincter defect >25% were 
offered a sphincter repair. In patients with a small rectal compliance an 
enterostoma was proposed (<60 ml) or strongly recommended (between 60 
and 100 ml) 12.  
Patients with a known 3rd degree sphincter rupture and as a result faecal 
incontinence were advised as other patients with faecal incontinence and 
the strong advice for a cesarean section with a next childbirth. If they were  
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not incontinent, depending on the size of the rupture, the possibility of a 
cesarean section for next childbirth was discussed. 
Advising re-anastomosis or enterostoma depended on the total impression 
of the anorectal function measured with anal pressures, rectal compliance 
and sphincter defects or atrophy.  
In patients with a fistula the extension of the fistula tract(s) with anal 
ultrasound determined the type of surgery in our hospital (fistulotomy in 
simple and curettage with mucosal advancement plasty in complicated 
fistulas).  
Patients where AFE was not indicated also received an advice. In patients 
with constipation a fibre enriched diet, additional fibres and laxatives were 
advised. When unsuccessful and not previously attempted, pelvic floor 
physiotherapy was advised. When constipation coexisted with complaints of 
prolapse, a defecography was advised. When surgery was considered 
(rectocele correction or colectomy) besides an AFE, also a colon transit time 
was performed. Patients with fissures were treated conservatively; when 
treatment failed they were referred to the surgeon and AFE was indicated. 
Hemorrhoids and mucosal prolapse were treated with rubber band ligation. 
A hemorrhoidectomy was advised only in refractory cases. Local causes of 
anal pain were treated according to their causes. When no local 
abnormalities were seen in patients with anal pain, fibres and referral to the 
anaesthesiologist was advised.  
Statistic analysis 
The results were described as mean with standard deviation. The χ2 test for 
independence and for trend, the Kruskal-Wallis test and the Wilcoxon 
matched-pair test were used when appropriate (GraphPad InStat Software, 
San Diego, Ca, USA).  
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RESULTS 
 
Response  questionnaires  
There were 216 first referrals for AFE, 181 (84%) females, mean age 51 years, 
(SD 15, range 15-82). Two patients had died, 167 patients (137 females (82%), 
mean age 51 years, SD 15, range 16-82) returned an adequate (almost all 
questions answered) questionnaire (78%). 
Indicated referrals 
Table 1 shows the indicated referrals. Of the 167 referrals, 109 (65%) were 
indicated. The most frequent referral was faecal incontinence, from which 
93% was indicated (7% had diarrhea).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Indicated referrals in the main groups of patients. 
a. 5 patients with diarrhea not indicated, b. only patients suspected of Hirschsprung / surgery 
indicated, IBD-inflammatory bowel disease* = % of all referrals  
 
 
 
 All  n 
(% of referrals)
Indicated n 
(% of that group) 
incontinence 71 (43) 66 (93) a 
constipation 31 (19)  6 (19) b 
3rd sphincter rupture 21 (13) 21 (100)  
pain 9 (5) 0 (0)  
re-anastomosis/enterostoma 9 (5)  8 (100) 
soiling 5 (3) 0 (0)  
IBD 4 (2) 4 (100) 
hemorrhoids 3 (2) 0 (0)  
anal atresia  2 (1) 2 (100)  
fistulas 2 (1) 2 (100)  
fissure 1 (1) 0 (0)  
other 9 (5) 0 (0) 
Total 167 (100) 109 (65*) 
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Non indicated referrals 
Two of the 31 patients with constipation had signs of anismus during physical 
examination and anal manometry. Of the 5 patients with soiling, 4 had a 
mucosal prolapse and/or hemorrhoids. The fifth patient had an anal fissure on 
inspection, not previously found. In two patients with anal pain a fissure was 
found, one treated conservatively and one eventually much later with 
surgery. AFE revealed no abnormalities in all patients besides high rest 
pressure in the patients with fissures. AFE did not influence therapeutic advice. 
Effect of treatment  
Symptoms improved in 54 patients (35%). In 88 patients (57%) symptoms 
were unchanged but patients were reassured. Despite treatment, 12 
patients (8%) deteriorated. The whole group improved one point on the 
VAS scale (5.1-6.1) (p<0.0001), for those improved (35%) this was even 3.2 
points (4.0-7.2). Both indicated and non indicated referred patients 
improved equally.  
The causes of faecal incontinence were: sphincter defect (14), neurogenic 
(37), combined incontinence (10), incontinence due to diarrhea (5) and 
incontinence due to small rectal capacity (<100 ml) (5). Within these 
groups, the largest improvement was seen in the combined incontinence 
group (1.8 point) (p=0.01). Patients with a small rectal capacity had no 
improvement at all.  
The actual therapies received by the patients according to the reason for 
referral are mentioned in table 2. Some patients received several therapies. 
The most frequent advice was medication, mainly fibres.  
Of all referred patients, only 17% were operated. No difference between 
effectiveness of conservative and surgical treatment could be observed on 
patient symptoms (p=0.09).  
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Table 2.  Reason for referral and effect of treatment on patients. 
*treatment as answered by patients, several treatments per patient possible,  # including all 
subgroups, § sphincter repair, † rectocele repair, ‡ fissurectomy, ◊ hemorroidectomy •p<0.0001 
 
Symptoms change after 
treatment  
2004-2006 Treatment according to the patients 
VAS category 
R
ea
so
n 
fo
r 
re
fe
rr
al
 
pa
tie
nt
s 
tr
ea
tm
en
t*
 
di
et
  n
 (%
) 
m
ed
ic
at
io
n 
n 
(%
) 
su
rg
er
y 
n 
(%
) 
ph
ys
io
th
er
ap
y 
n 
(%
) 
  e
xp
ec
ta
ve
  n
 (%
) 
be
fo
re
 
  af
te
r 
 
im
pr
ov
ed
 
re
as
su
re
d 
w
or
se
 
Incontinence# 71 100 8 32 12§ 26 22 5 5.7 20 39 7 
Constipation 31 35 3 12 3†  7 10 5 6.2 11 17 1 
3rd  sphincter 
rupture 
21 22 2 1  2 17 7.1 7.2 2 15 1 
Anal pain  9 8  1 1‡  6 3.5 5.1 3 5  
Surg/ Stoma 8 8   6  2 6.3 7 2 4  
Soiling 5 7 2 3 2   3.4 4.8 3 1 1 
IBD 4 4  2   2 4.8 6.5 2 2  
Hemorrhoids 3 6 1 3 2◊   4.3 6.3 2 1  
Anal atresia 
 
2 2  1   1 6 7.5 2   
Fistula 2 2     2 4 5.5 1 1  
Fissure 1 2  1 1‡   2 8 1   
Pouchitis 1 1     1 8 7   1 
Other 9 12 1 1 8 1 1 5.1 6.7 5 3 1 
Average (SD)        5,1• 
(2.4) 
6.1• 
(2.3)
   
Total (%) 167 209 17 
(8) 
57 
(27) 
 35 
(17) 
 36 
(16) 
 64 
(31) 
  54 
(35) 
88 
(57) 
12 
(8) 
                                                                        
  30  
AFE induced little stress, indicated by an average pain score of 7 (SD 2.7) 
and a discomfort score of 7.2 (SD 2.8). Two patients with fistulas experienced 
the examination as unpleasant and painful due to the hydrogen peroxide 
injection in their fistula tract during anal ultrasound. Thirty-five females (26%) 
preferred to be examined by a female doctor while the remaining 102 
(75%) had no preference. Twenty-six males (93%) had no preference and 
the remaining two (7%) preferred a male and a female doctor, respectively 
(p<0.0001). Dutch ethnic minorities did not influence these data.  
Questionnaires referring doctors 
Of the 214 questionnaires, 102 (48%) responses were obtained. The advice 
was nearly always implemented (96%). The quality of the advice was 
considered good in 76% and neutral in 24%. All doctors except one (98%) 
were willing to refer again.  
Agreement between proposed and followed advises. 
The proposed and followed therapies are shown in table 3. Therapies could 
also be a combination of medication, physiotherapy or surgery. Dietary 
advice was always followed (100%), while surgical advice was generally 
followed (89%). Less accepted advices included medication (71%) and 
physiotherapy (73%) (p=0.005, 99%CI). 
 
 All 
Therapies 
(%) 
Diet  
(%) 
Medication 
(%) 
Physiother.    
(%) 
Expectative 
(%) 
Surgery 
(%) 
Followed 130 (80) 7 (100) 54 (71) 32 (73) 31 (100) 36 (90) 
Not 
followed  
32 (20) 0 22 (29) 12 (27) 0  4 (10) 
Total 162 (100) 7 (100) 76 (100) 44 (100) 31 (100) 40 (100) 
 
Table 3.  A comparison between the proposed therapeutic advices and 
followed therapy. A therapy can consist of more components.  
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DISCUSSION  
The 78% response to the questionnaires of the patients was good. In our 
previous study we reported a similar result 2. Only 65% of the referrals were 
indicated. In 35% the diagnosis could have been established by clinical 
examination or added nothing. This is a signal that more communication and 
education is warranted, especially in times with restrictions and limited 
resources. However, many of the referred patients suffered from chronic 
symptoms, bringing both patient and doctor to despair. The possibility of 
referring the patients to another centre may come as a welcome alternative. 
The symptoms of the whole group improved an average of one point from 
5.1 to 6.1 on a scale of 10. Actual improvement took place in 35% of the 
referred patients; they improved an average of 3.2 points. The moderate 
improvement might be explained by the fact that it concerned patients with 
chronic disorders, already treated conservatively for a long time. Success was 
not related to a specific symptom, diagnosis or treatment, only the five 
patients with faecal incontinence due to small rectal capacity did not 
improve. Deterioration in 8% of the patients was mainly due to the fluctuating 
course of the chronic complaints combined with their reluctance to follow 
the advice. In 80% the patients followed the advices. Medication and 
physiotherapy were the least applied therapies (table 3). Some disagreement 
between advised and followed therapy could be explained by the fact that 
patients considered fibres a diet instead of medication. Physiotherapy was 
advised in 44 patients (26%) and effectuated in 32 (73%). Ten years ago this 
was only respectively 18% and 67% 2. Increasing interest in pelvic floor 
disorders and special training for physiotherapists has certainly contributed to 
the change in attitude towards physiotherapy 1,13. Although therapeutic 
advices were given after AFE, actual improvement in symptoms is not 
necessarily caused by AFE.  A placebo effect due to the referral to a 
specialized centre and the knowledge present in a 3rd referral centre may 
play a role. This is comparable with biofeedback studies for faecal 
incontinence, were the added value of the biofeedback was very difficult to 
separate from the received specialized care and treatment 13,14.  
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The examination was generally well tolerated, except in two patients with 
fistulas who experienced the examination as painful. This was caused by local 
injection of hydrogen peroxide into the external fistula opening in order to 
visualize the fistula tract. Remarkable is that ten years ago only 13% of the 
females 2 and now 26% of the females preferred a female doctor. The larger 
number of referred Dutch ethnic minorities could not explain this. 
Although the questionnaire was retrospective and has not been officially 
validated (we used it before 2) has proven to be very useful. Questions about 
for instance surgery or 3-6 months of physiotherapy could not easily be 
misunderstood. In patients treated in our own hospital follow up data were 
also obtained from the (electronic) patient files and no discrepancies were 
found with the answers provided by these patients.  
Our treatment advice strategy is derived from clinical practice and the 
literature. In patients with faecal incontinence, regulating defecation and 
thickening of the faecal mass has proven to be effective and should always 
be tried first 15-17. Biofeedback aimed at improving rectal sensation, recto-
anal coordination and training external anal sphincter contraction is the next 
step and has a success rate varying from 40-85% and is closely related to 
patient motivation 18. Diarrhea should be properly diagnosed and treated 
before referring the patient for AFE since this overwhelming factor makes it 
impossible to establish the (possible) importance of anorectal causes. A 
rectal capacity between 60 and 100 ml will lead to faecal incontinence in 
50% and <60ml in 100% of patients 12; they will often need an enterostoma. 
Patients with faecal incontinence with a significant sphincter defect (>25%) 
without severe neuropathy leading to atrophy can be identified as suitable 
candidates for a sphincter repair 1,19-21.    
In our group of incontinent patients only 12 (18%) ultimately underwent 
sphincter repair. Two patients were later referred for sacral neuromodulation 
elsewhere and eleven patients 22 were treated with SECCA® (radio frequent 
energy application to the external sphincter 23,24). 
Women who experienced a 3rd degree sphincter rupture are indicated for 
AFE, even without complaints. There in always some damage to the external 
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anal sphincter and appropriate advices concerning defecation regulation, 
physiotherapy and possible future cesarean section can be discussed. 
Most patients with constipation were referred for assessment of 
anismus/hyper tonic pelvic floor or rectocele. Generally AFE is not needed in 
these patients. Both anismus and a rectocele can be diagnosed by proper 
rectal examination 6,25,26. When prolapse complaints dominate a 
defecography is indicated to demonstrate a possible enterocele as this can 
be corrected surgically. In patients with constipation correction is not 
indicated in accidentally found intussusception since the obstructed 
defection will not improve 26-29. AFE is indicated when (partial) colectomy is 
considered to be informed about the continence reserve. For patients with 
fistulas anal endosonography demonstrates the fistula tracts and anal 
manometry will establish the continence reserve 21,30-33. In patients with soiling 
(anal secretion), medical history, good physical and rectal examination and 
an additional proctoscopy have proven be sufficient to establish a  
diagnosis 10, without the need for AFE, as was shown again in our patients. For 
patients with pain AFE does not contribute 34. Suspected discrete 
abnormalities e.g. an occult abscess, could not be demonstrated in our study 
as well. Sometimes a fissure is found in these patients, diagnosed on the basis 
of the medical history and rectal examination. In patients with a fissure high 
pressures are usually found using manometry, but this does not alter  
therapy 35. Only in those who where conservative measures have failed and 
will undergo surgery AFE seems indicated. In patients with haemorrhoids anal 
manometry can also reveal high pressures and anal endosonography can 
demonstrate a thickened mucosa; however, these findings have no 
influence on therapy 36,37. AFE is indicated in patients with an enterostoma 
when re-anastomosis is considered. In some rare disorders like anal atresia 
AFE can also be indicated to document anorectal problems and help 
choose a specific therapy.  
 
In conclusion, Referral for AFE was indicated in 65%, communication and 
education to colleagues seems warranted.  Indications are faecal  
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incontinence without diarrhea, 3rd degree sphincter rupture, pre-operative for 
stoma or re-anastomosis, fistula, fissures or constipation. Anal ultrasound is 
always indicated in patients with fistula, anal manometry and rectal 
compliance when impaired continence reserve is suspected. Generally, in 
patients with constipation and soiling the medical history, physical 
examination and additional proctoscopy is sufficient and AFE is not 
necessary.  
In 80% the patients followed the advices. After AFE 92% benefited (35% of the 
patients improved and 57% was reassured). AFE is well tolerated. Women 
preferred a female doctor in 26%.  
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COMMENTS 
Background 
Anorectal disorders like faecal incontinence, peri-anal fistula, pre-operative 
decisions for stoma e.g. are distressing and isolating conditions, with have a 
large impact on quality of life. With restricted resources it is important to 
make a good selection of referrals for anorectal function evaluation, those 
patients who benefit most. In this study we established the indicated 
referrals our tertiary referral centre for patients with anorectal symptoms, the 
effect of the advised treatment and the discomfort of the tests. 
Research frontiers 
A clinical referral is indicated when disease can be demonstrated or 
excluded on the basic of anorectal function evaluation and when it has 
further therapeutical consequences. Which patients benefit the most from 
anorectal function tests (by reduction of symptoms or reassurance) is 
unclear.  
Innovations and breakthroughs 
Most studies mention anorectal function tests in relation to anorectal 
pathology limit themselves to pre- and post-treatment results. Therefore it 
often remains unclear whether anorectal function evaluation leads to 
relevant findings or subsequent change of therapy. Literature concerning 
this issue is scarce. 
The aim of our study was to determine the indicated referrals to our tertiary 
center for patients with anorectal symptoms, the effect of the advices on 
their complaints and the perceived discomfort for the patients during 
anorectal function evaluation. 
Applications 
It is very important to understand the usefulness of the anorectal function 
evaluation to provide referrals of those patients, which could benefit the 
most.   
Indications for anorectal function evaluation are faecal incontinence 
without diarrhea, 3rd degree sphincter rupture, pre-operative for stoma or 
re-anastomosis, fistula, fissures or constipation. Anal ultrasound is always 
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indicated in patients with fistula, anal manometry. Rectal compliance is 
indicated when impaired continence reserve is suspected. Generally, in 
patients with constipation and soiling the medical history, physical 
examination and additional proctoscopy is sufficient and anorectal 
function evaluation is not necessary. 
Terminology 
Anorectal function evaluation consists of several tests: 
• anal manometry - establishes anal pressures  
• rectal compliance - measures sensitivity and the volume of the 
rectum 
• anal endosonography - visualizes possible defects or atrophy of the 
anal sphincter complex 
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Abstract 
Background and aim 
Faecal incontinence is a devastating complaint. Even after conservative 
treatment many patients still remain incontinent. Few patients have a sphincter 
defect suitable for repair. Other emerging surgical therapies like dynamic 
gracilis plasty, neuromodulation or artificial bowel sphincter, carry side effects 
and show only moderate improvement. Temperature controlled radio 
frequency (RF) energy (SECCA®) has shown promising results in the USA. Local 
tightening seems the mode of action with possible increased rectal sensitivity. 
We investigated the effectiveness of RF and possible changes in the anal 
sphincter with 3D-ultrasound in patients with faecal incontinence. 
Patients and methods  
Eleven females, mean age 61 years (49-73) with long standing faecal 
incontinence were included. Patients with large sphincter defects and anal 
stenosis were excluded.  
The SECCA® procedure was performed under conscious sedation and local 
anaesthesia. Oral antibiotics were given. In 4 quadrants on 4 or 5 levels 
(depending upon length of the anus) RF was delivered with multiple needle 
electrodes. Patients were evaluated at 0, 6 weeks, 3 and 6 months and one 
year. Three dimensional anal ultrasound was performed at 0 (before and 
after the procedure), 6 weeks and 3 months. Anal manometry and rectal 
compliance measurement were performed at 0 and 3 months.  
Results  
At 3 months, 6 of 11 patients improved, which persisted during follow up of 
one year. The Vaizey score changed from 18.8 to 15.0 (p=0.03) and in those 
improved from 18.3 to 11.5 (p=0.03). Anal manometry and rectal 
compliance showed no significant changes, there was a tendency to 
increased rectal sensitivity concerning urge and maximal tolerated volume 
(both p=0.3). Responders compared to non-responders showed no 
difference in test results. Side effects were local haematoma (2), bleeding 3  
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days (1), pain persisting 1-3 weeks (4) and laxatives related diarrhea during 
1-3 weeks (4).  
Conclusion   
The SECCA® procedure seems promising for patients with faecal 
incontinence with a persisting effect after one year. No significant changes 
in tests were found.  
 
 
 
Presented at the UEGW October 2006 (Berlin, Germany), DDW May 2006 
(Los Angeles, CA, USA) and the Dutch Society of Gastroenterology October 
2005 (NVGE, Veldhoven, The Netherlands) 
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INTRODUCTION 
Faecal incontinence is a complex problem that has a high impact on the 
quality of life 1. Damage to the anal sphincters (external and/or internal 
anal sphincter defect) or to the pudendal nerve (denervation) during 
vaginal delivery are the most frequently encountered cause in women with 
faecal incontinence. Anal sphincter trauma and damage of the pudendal 
nerve often occur simultaneously 2. 
The exact incidence of faecal incontinence is hard to determine and 
relates to the reluctance to report this complaint due to embarrassment. 
Several studies with questionnaires in the general population report 
prevalence up to 7%, increasing with age 3. 
Treatment of faecal incontinence starts conservatively consisting of 
regulation of defecation with a fibre enriched diet, physiotherapy of the 
pelvic floor and medication inducing constipation like loperamide or 
cholesteramine. When unsuccessful, patients with an anal sphincter defect 
can be offered a sphincter repair. New surgical options for patients with or 
without a sphincter defect are dynamic gracilis plasty 4 or sacral 
neuromodulation 5 or artificial bowel sphincter 6. Yet all these treatments 
have success percentages defined as substantial improvement varying 
around 70%, carry some side effects, demand specific expertise and are 
not generally available. 
A new emerging technique is radiofrequent energy (RF) delivery to the 
anorectal junction. Tissue heating with the delivery of RF energy results in 
immediate collagen contraction, followed by local wound healing, 
remodelling and tightening 7. It has been applied for non gastrointestinal 
diseases (obstructive sleep apnoea, snoring, benign prostatic hyperplasia, 
joint capsule laxity) and has also been successfully used in the 
gastroesophageal junction for gastroesophageal reflux disease 8. 
Two recent open-label trials suggested improvement in the faecal 
incontinence score and the quality of life 9,10, one with a follow up of two 11 
and five 12  years. The clinical results varied in these two studies. The 
technique is feasible as an outpatient procedure and has little side effects 
                                                                        
  45  
concerning local discomfort. Anorectal function tests suggested some 
changes in rectal sensitivity, but no other changes in anorectal function or 
ultrasound were found.  
The aim of this pilot study was to treat patients with SECCA® to establish the 
decrease of their complaints of faecal incontinence and to study possible 
changes in anorectal function and three dimensional ultrasound. 
 
PATIENTS AND METHODS  
Patients 
Patients with faecal incontinence for at least six months, a Vaizey 
incontinence score 12 of at least 12 and failure of conservative treatment, 
based on diet recommendations, antidiarrheals and physiotherapy without 
a significant sphincter defect suited for sphincter repair were included. 
Patients were excluded if they had proctitis or inflammatory bowel disease, 
chronic diarrhea, chronic constipation, overflow incontinence, previous 
ileoanal or coloanal anastomosis, rectal prolapse, anal stenosis, anal fissures 
or fistulas, pelvic radiation, coagulation disorders or the use of 
anticoagulants. Patients with haemorrhoids or mucosal prolaps were 
treated first with rubber band ligation and could be included 6 weeks later. 
Medical history was obtained at baseline and after 3, 6 and 12 months 
including Vaizey score (0 = no complains, 24 = fully incontinent) 13, 
improvement (none, slightly improved and improved) and side effects. 
On digital palpation sphincter pressure was scored as low, normal or high. 
Defects were also described and measured in hours (1-12 hours, with 12 
hours being anterior).  
All patients underwent colonoscopy in their previous work up.   
Methods 
Anal manometry 
Anal manometry was performed with an open tip perfusion system using a 
disposable catheter with four 90o radial orientated side ports connected to 
a Polygraf ID (Medtronic, Skovlunde, Denmark). After calibration, the 
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catheter is automatically withdrawn by a puller at a speed of 3 cm per 
second.  
The average increase in pressure to the atmosphere pressure is the 
maximum basal pressure (MBP). The length over which the increase is 
present is the sphincter length (SL). The catheter is introduced again and 
manually withdrawn with steps of 0.5 cm, while the patient is asked to 
squeeze maximally. The average maximum increase in pressure above the 
existing basal pressure is the maximum squeeze pressure (MSP). The 
distension reflex was elicited by inflating the rectal balloon and the volume 
was registered. 
Rectal compliance measurement 
A compliant balloon catheter is introduced into the rectum. Air is inflated 
manually with a syringe with a speed of 60 ml in 15 seconds to a maximum 
to 300ml. The volume of first sensation (FS), urge to defecate (Urge) and 
maximum toleration (MTV) is notated. 
Three dimensional (3D) anal ultrasound 
Anal ultrasound was performed using a three dimensional  diagnostic 
ultrasound system (Falcon type 2101 EXL, B-K Medical, Naerum, 
Denmark) with a 5-16 MHz rotating endoprobe (type 2050, focal range 2 
to 4.5 cm) with an internal puller (diameter 1.7 cm) producing a 360° 
view. 3D anal ultrasound was performed according to a standard 
procedure with an automatic puller. The endoprobe was covered with a 
lubricated condom which was filled with ultrasound gel. The probe was 
then introduced into the rectum and a recording was made of the distal 
part of the rectum, the puborectalis muscle and the anal canal. After 
the ultrasound, images were reconstructed to three dimensional images 
by computer software.  
Defects 
External anal sphincter (EAS) defects were described as hypoechogenic 
lesions and the extent of the defect was axially measured in hours (1-12 
hours, with 12 hours anterior, three hours left lateral, etc). The length of the 
defect was indicated as proximal, distal or total. A defect comprised at 
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least one hour of the circumference of the sphincteric ring. Internal anal 
sphincter (IAS) defects were described as a disruption of the internal ring. 
Atrophy  
Atrophy of the EAS was judged upon its reflection of the outer interface 
(border external anal sphincter and subadventitial fat), reflection pattern 
and length. Atrophy was scored as none (clearly visible outer interface, 
mixed reflection pattern), moderate (partly visible outer interface, 
intermediate reflection, moderate shortening) and severe (hardly visible 
outer interface, hyperechogenic reflection pattern, severe shortening) 14. 
SECCA® procedure   
Patients were treated in the outpatient department in the endoscopy unit. 
Prophylactic antibiotics (metronidazol 500mg and amoxycilline 
500mg/clavulanacid 125mg) were taken before the procedure and 
repeated afterwards and 8 hours later. One hour before the procedure 
patients received a rectal enema. An intravenous catheter was placed 
and sedation with 0.05 mg fentanyl and 7.5 mg midazolam was 
administered. During the procedure more sedation could be added when 
necessary. Local perianal anaesthesia with 10 ml lidocaine 0,5% with 
epinephrine 1:200.000 was administered in 4 quadrants. A standard 
electrosurgical ground pad was placed on the patient’s back or flank 
according to hospital safety standards. The radio frequency generator was 
turned on, the ground pad connected to the generator, the SECCA® hand 
piece connected to the generator, and the IV tubing and sterile water bag 
attached to the hand piece and the pump on the generator.  
The SECCA® device (figure1) comprises an anoscopic barrel with four 
nickel-titanium cursed needle electrodes deployed from within (22 gauge, 7 
mm length; Curon medical, SunVally, CA, USA). The hand piece is 
positioned under direct vision at the proper position in the anal canal (figure 
2), needles deployed into the muscle (figure 3). Irrigation of the mucosa 
begun via the coolants ports on the hand piece, and RF (465 kHz, 2-5 Watt) 
was delivered for 60 seconds, resulting in 4 thermal lesions. Target lesion 
temperature was 85°. After the 60 seconds interval, the needles were 
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retracted and the hand piece was repositioned. In total 5 levels, starting at 
the dentate line, going up with steps of 1 cm until 4 cm above the dental 
line, and four quadrants, are treated, thus 80 RF deliveries. When during the 
procedure displacement of the needles or drop out of the device occurred 
before 30 seconds, the procedure was repeated at the place after 
repositioning. If the recto-vaginal septum was thin and short, less than 5 
applications were performed anteriorly. The RF procedure took about 30 
minutes, including preparation about one hour. 
 
 
        
 
Figure 1. SECCA® Hand piece (probe)   Figure 2. Introduction of probe with 
                                                                               mucosa  visible 
 
a       b 
Figure 3. Schematic design of the probe in the anus (a) and after treatment 
(b) 
                                                                        
  49  
Post-Treatment Care 
Patients were recovered in a monitored unit for one hour or longer when 
necessary and were subsequently discharged. After the treatment and 8 
hours later the antibiotic intake was repeated. Patients were refrained from 
NSAID use during two weeks, paracetamol was allowed when needed. 
Constipation was treated with a polyethylene glycol when necessary. 
Patient follow-up was scheduled at six weeks, 3 months, 6 months, 9 months 
and one year. 
Statistical analysis 
Results were be described and presented as mean, median and 
interquartile range when suitable. Differences were calculated with the 
paired T-test. 
RESULTS 
Clinical response 
Eleven patients were included, all women, mean age 61 years (range 49-
73). Their characteristics are shown in table 1. The mean time of complaints 
of faecal incontinence was 12 years (range 2-38). All but one had vaginal 
deliveries. 
 
age years with 
faecal 
incontinence 
vaginal 
deliveries
anorectal 
trauma 
anorectal 
surgery 
wears 
pads 
stool stool 
frequency
urinary 
incontinence 
other 
disease 
Patients improved in continence 
55 30 0 - - yes norm 1 day no Sjøgren 
60 7 3 episiotomy hysterectomy yes norm 1 day no cva 
60 3 3 episiotomy - yes soft 2 day no type 2 DM 
58 3 2 - - yes norm 2 day yes melanoma 
49 5 2 episiotomy - yes solid 1 per 3 
day 
no no 
67 2 6 - - yes norm 1 day no hypertension 
Patients not improved in continence 
64 38 2 - hysterectomy yes soft 3-4 day yes rheumatic 
disease 
73 4 2 straining - yes soft/ 
norm
0-1 day no regulated 
thyroid dis 
57 10 2 episiotomy - no soft 2 day no no 
60 2 2 3th degree 
sphincter 
rupture 
bladder 
fixation 
yes hard 1 per 3 
day 
yes haemo- 
chromatosis 
60 10 2 - - yes soft 2 day no hypertension 
 
Table 1. Patient baseline characteristics. 
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Six of eleven (55%) patients stated that they had improved (one patient 
only slightly) (table 2). The Vaizey scores of all patients decreased from pre-
treatment to 3 months from 18.8 to 15.0 (p=0.03, mean 3.7, SD 4.0) and of 
the improved from 18.3 to 11.5 (p=0.03, mean 6.8, SD 4.5), persisting after 6 
and 12 months. There were no differences in biological characteristics 
between the responders and none responders. 
 
 
Patient Vaizey 0 Vaizey 3 months Vaizey 6 months Vaizey 12 months  
1 19 11 11 11 improved 
2 19 12 12 12 improved 
3 22 22 22 22 no 
4 19 19 19 19 no 
5 21 10 10 10 improved 
6 17 14 14 14 improved 
7 19 19 19 19 no 
8 15 9 9 9 improved 
9 19 13 13 13 slightly improved 
10 18 18 18 18 no 
11 19 19 19 19 no 
 
mean 19 15 15 15  
SD 2 4 4 4  
 
Table 2. Vaizey incontinence score  in time. 
 
 
The remarks of the patients were extensively registered. Those who 
improved were very pleased with the treatment. The most striking remarks 
were that the four patients said that they felt urge and now had 5 minutes 
to reach the toilet instead of one. No predictive factors concerning the 
demography of the patients and their clinical result or Vaizey score was 
found. 
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Anal manometry, rectal compliance measurement and 3D anal ultrasound  
Anal manometry and rectal compliance showed no significant changes 
after 3 months, neither in those who improved nor in those who did not. 
There was a tendency of decrease in urge and MTV after 3 months, but this 
was not significant in the whole group (both p=0.3) as well in the improved 
(p=0.8 and p=0.6) and those who did not (p=0.6 and p=0.8). 
Anal ultrasound showed pre-treatment a small scar in the external anal 
sphincter in one patient. Slight atrophy was seen in all patients. Immediately 
after the procedure no changes were seen, except for some small fluid 
accumulations due to the local anaesthetic in some patients. After 3 
months, no differences with pre-treatment anal ultrasound were seen  
(table 3). 
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                      anal manometry    rectal compliance 
 
MBP 
0 
MBP 
3 
MSP 
0 
MSP 
3 
SL 
0 
SL 
 3 
DRvol 
0 
DRvol 
3 
FS 
0 
FS 
 3 
URGE 
0 
URGE 
3 
MTV 
0 
MTV 
3 
Patients improved in continence 
45 55 75 60 3 4 20 10 15 40 210 130 240 200 
20 10 30 30 3 x 10 20 145 100 270 190 320 240 
70 40 30 30 4,5 4,5 20 50 55 40 80 150 125 200 
20 20 10 10 3 3 40 20 20 45 100 80 165 100 
40 40 20 40 4 4 20 20 75 15 250 180 315 210 
20 20 25 30   10 20 70 180 90 200 145 240 
Mean (SD) 
36 
(20) 
31 
(17) 
32 
(23) 
34 
(16) 
3,5 
(0,7) 
3,9 
(0,6) 
20 
(11) 
23 
(14) 
63 
(47) 
70 
(61) 
167 
(86)^ 
155 
(45)^ 
218 
(86)' 
198 
(51)' 
Patients not improved in continence 
30  20  3  20        
50 55 40 50 3,5  30 30 120 70 150 100 240 200 
40 40 20 20 4 4 10 20 15 15 50 35 80 70 
30 20 15 15 3 3,5 20 40 155 145 210 200 240 245 
30 20 10 30 3,5  30 30 70 100 140 110 250 240 
Mean (SD) 
36 
(9) 
34 
(17) 
21 
(11) 
29 
(15) 
3,4 
(0,4) 
3,8 
(0,4) 
22 
(8) 
30  
(8) 
90 
(61) 
83 
(55) 
138 
(66)^^ 
111 
(68)^^ 
203 
(82)'' 
189 
(82)'' 
All patients mean (SD) 
36 
(15) 
32 
(16) 
27 
(18) 
32 
(15) 
3 
(0,5) 
4 
(0,5) 
21 
(9) 
26 
(12) 
74 
(52) 
75 
(56) 
155 
(76) # 
138 
(56) # 
212 
(80) 
* 
195 
(61) 
* 
 
Table 3. Anorectal function tests (anal manometry and rectal compliance) 
at baseline and after 3 months. 
 
MPB = maximum basal pressure (mmHg), MSP = maximum squeeze pressure (mmHg), SL = 
sphincter length (cm), DRvol = volume to evoke distension reflex, FS = first sensation (ml), URGE = 
urge to defecate (ml), MTV = maximum toleration (ml), 0 = before treatment, 3 = results after 
three months. 
^p=0.8, 'p=0.6, ^^p=0.6, ''p=0.8, #p=0.3 , *p=0.3 
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Side effects 
The procedure was well tolerated and almost without discomfort. Two 
patients had slight and one moderate pain during the procedure. 
There were no major side effects. No hospital admissions or outpatient clinic 
visits were needed. Eight patients (73%) had a slightly painful anus during 
the first 1-3 days, 2 patients moderate pain and one patient severe pain 
during one week. Five patients (45%) had haematoma and/or minor 
bleeding during 2-7 days. Three patients (27%) had antibiotic associated 
diarrhea and one had subsequently transient worsening of the faecal 
incontinence. 
 
DISCUSSION  
This prospective study has demonstrated that RF energy application has a 
significant therapeutic effect in some patients on the symptoms of faecal 
incontinence.  
The results of our study are comparable with those described by Effron 10 in 
a multicentre study in 50 patients (43 women) after 6 months. We had a 
clinical response of 55% compared to 60% in the Effron study. The faecal 
incontinence scores were also quite similar. Although we used the Vaizey 
score and Effron the Cleveland Clinic Incontinence score, patients 
improved respectively in these scores 13% and 17% respectively. 
The initial study of Takahashi 9 from 2002 in 10 women showed better results 
after 2 years 11 persisting after 5 years 12. Here 80% of the patients improved 
and the Wexner score improved from 13,5 to 5 (43%).  
In our patients the result was reached after 3 months and remained stable 
throughout the year. In the Effron study there was an additional 
improvement of 3 patients (6%) after 6 months. 
Takahashi’s patients remained stable, after 5 years their situation was 
comparable with 3 months 12. No further improvement in the Takahashi 
study was seen between 6 and 12 months. So basically the improvement 
can be judged after 3 months. 
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We did not obtain a faecal incontinence quality of life (FIQL) score in our 
patients or social function questionnaire (SF-36). Since the exact mechanism 
of improvement is not known, we interviewed extensively our patients. A 
very interesting and striking remark was that four patients were very pleased 
that they were able to retain there faeces for a longer time. This earlier 
sensation of an impending bowel movement permits the patient to reach 
the toilet in time, thus making the difference between incontinence and 
continence. This improvement however did not translate into an improved 
Vaizey score, since an improvement up to 15 minutes is required for a 
change on this scale. This underlines the importance of not only 
questionnaires, but also the remarks of the patients. For future studies it 
seems wise to perform both questionnaires and remarks of the patients, 
since the latter are not always caught in a questionnaire. 
We experienced no major side effects. Effron 10 had initially some serious 
side effects with two severe ulcerations in two patients, leading in one 
patient to worsening of the complaints. These adverse events were 
procedure related leading to a change in the protocol by increased 
mucosal cooling. The third patient had a bleeding 30 days after the 
procedure from a haemorrhoidal vein requiring suture ligation. Takahashi 9 
also reported one serious bleeding requiring ligation. 
All our patients had some local anal pain in the first days, 73% resolved 
within 1-3 days. Only one patient had severe pain during one week. Effron 10 
reported severe pain in 10%. Self limiting bleeding was seen in 45%, Effron 10 
reported 5 (10%) minor bleeding and Takahashi 9 3 (30%). In 3 (27%) patients 
we observed diarrhea associated with antibiotics and Effron in 6 (12%). 
Effron 10 also encountered fever in two patients without signs of local 
infection. 
Takahashi 9 reported a smaller first rectal sensation and rectal volume.  
Effron 10 could not confirm this in his patients, but in a subgroup analyses 
from his own clinic there was a decrease in first rectal sensation. We could 
not confirm this, there was a tendency towards a decreased urge and 
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maximum tolerated volume. Four patients clearly indicated that they felt 
urge earlier, e.g. before that it had passed the anus.  
Considering the working mechanism, fibrosis and contraction in the 
sphincter it seems logic that if any changes are found, this has to be 
sensation because of a smaller distal rectal volume. In addition, our 
measurement tools are probably not very sophisticated to reveal small 
changes in anorectal function 15. 
Changes in anal pressure were not found. Other treatments for faecal 
incontinence like sphincteroplasty 16,17 or sacral neuromodulation 18,19 have 
not always demonstrated increased anal pressures in those who improved. 
Anal ultrasound could not reveal any changes. In several patients 
temporary fluid collections were seen due to the local anaesthetic, but no 
structural changes were found after 3 months. 
Although not all patients improve and some of those who improve are not 
totally symptom free, the treatment carries little side effects and is easy to 
perform on an out patient basis. Also it does not preclude patients from 
undergoing other procedures such as graciloplasty, sacral neuromodulation 
or artificial bowel sphincter. These surgical procedures however are not 
without complications and again success lies around 70%. Therefore, the 
SECCA® procedure merits more attention and warrants a randomized 
controlled trial, which is currently underway. 
 
Conclusions 
The SECCA® procedure seems a feasible, safe outpatient procedure with a 
moderate clinical effect in patients were diet regulation and physiotherapy 
have failed and sphincteroplasty is not indicated. The working mechanism is 
probably increase in local sensation thus permitting the patient more time 
to reach the toilet. A randomised controlled trial seems warranted. 
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Abstract           
Aim 
To evaluate how many patients with endometriosis had concomitant 
irritable bowel syndrome (IBS) and/or constipation according to Rome III 
criteria. Furthermore, the value of an additional gastroenterological consult 
with therapeutic advice was evaluated.  
Patients and methods  
Patients with proven endometriosis were included in prospective, 
monocentre study. A questionnaire was taken regarding IBS and chronic 
constipation. Patients who complied with Rome III criteria were referred to 
our gastroenterological outpatient clinic. 
Results  
In total 101 patients where included. Endometriosis was diagnosed surgically 
in 97%, and visually in the vagina in 3%. Fifteen percent of them had 
additional IBS and 14% had functional constipation without IBS. Of the 22 
patients finally presented to the gastroenterologist 5 had a significant 
stenotic rectosigmoid and were treated surgically. The remaining 17 
patients were treated conservatively. Defecation symptoms improved in 
86% and pain was reduced in 64%.  
Conclusion 
In patients with endometriosis, 30% had also IBS or constipation. Referral to a 
gastorenterologist resulted in improvement of 86% of defecation and 64% of 
pain reduction.  
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INTRODUCTION 
Endometriosis is a chronic debilitating gynaecological condition which 
often presents with symptoms that may be similar to those of gastrointestinal 
disorders. It is characterized by the presence and proliferation of 
endometrial tissue outside the uterine cavity, which occurs in approximately 
10% of women of reproductive age. It causes pain and infertility affecting 
millions of women worldwide 1,2. Irritable bowel syndrome (IBS) is a functional 
bowel disorder in which abdominal pain or discomfort is associated with 
defecation or change in bowel habit and with features of disordered 
defecation 3. Throughout the world, about 10% of adults have symptoms 
consistent with IBS, and most studies find a female predominance 3,4. IBS 
occurs usually in three subtypes; with diarrhea, constipation or mixed type.  
The worsening of IBS symptoms during menstruation in women with 
endometriosis may obscure the diagnosis of IBS 5.  
The aim of the study was to evaluate how many patients with proven 
endometriosis had also IBS and/or constipation according to the Rome III 
criteria. Furthermore, we investigated the value of an additional consult by 
the gastroenterologist and the results of therapeutic advice.  
 
PATIENTS AND METHODS  
Patients 
From October 2006 to October 2007, 101 patients with established 
endometriosis were enrolled in this prospective study. All patients were 
referred to the Endometriosis Centre VUmc for second opinion from 
affiliated hospitals or directly from General Practitioners. All patients gave 
informed consent for participation in this study. The study was approved by 
the VU University Medical Centre Ethic Commission. 
Methods 
Initially all patients were evaluated by one of four gynaecologists of the 
endometriosis team. During the first visit detailed questionnaires were 
completed for each patient. They included questions on endometriosis 
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related complains (dysmenorrhoea, deep dyspareunia, dyschezia, cyclic 
rectal bleeding, dysuria, hematuria), previous operations and hormonal 
treatments, as wel as questions regarding IBS (table 1) and chronic 
constipation (table 2). Endometriosis was diagnosed during laparoscopy/ 
laparotomy as well as by visual inspection of vagina. The follow-up of the 
patients was 12 months. The medical history and results of all examinations 
performed in our hospital were registered. 
The average time between first complains of the patients and diagnosis of 
endometriosis was also established.  
All patients, which met the diagnostic criteria of IBS and/or chronic 
constipation (table 1, 2) were offered referral to our gastroenterological 
outpatient clinic for further diagnostics and advice. Improvement was 
defined as a decrease of symptoms by 50%.   
 
Diagnostic criteria for Irritable Bowel Syndrome 
Recurrent abdominal pain or discomfort* at least 3 days per month in the last 3 
months associated with 2 or more of the following:  
1. Improvement with defecation 
2. Onset associated with a change in frequency of stool 
3. Onset associated with a change in form (appearance) of stool 
*Discomfort means an uncomfortable sensation not described as pain.  
Subtyping IBS  
1. IBS with constipation (IBS-C) – hard or lumpy stools ≥25% and loose 
(mushy) or watery stools < 25% of bowel movements 
2. IBS with diarrhea (IBD-D) – loose (mushy) or watery stools ≥25% and hard 
or lumpy stool <25% of bowel movements 
3. Mixed IBS (IBS-M) – hard or lumpy stools ≥25% and loose (mushy) or watery 
stools  ≥25% of bowel movements 
4. Unsubtyped IBS – insufficient abnormality of stool consistency to meet 
criteria for IBS-C, D or M 
 
Table 1. Diagnostic criteria and subtyping IBS 3 
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Diagnostic criteria for Functional Constipation 
1. Must include 2 or more of the following: 
a. Straining during at least 25% of defecations 
b. Lumpy or hard stools in at least 25% of defecations 
c. Sensation of incomplete evacuation for at least 25% of 
defecations 
d. Sensation of anorectal obstruction/blockage for at least 25% of 
defecations 
e. Manual manoeuvres to facilitate at least 25% of defecations 
f. Fewer than 3 defecations per week 
2. Loose stools are rarely present without the use of laxatives 
3. There are insufficient criteria for IBS 
 
Table 2. Diagnostic criteria for Functional Constipation 3 
 
Statistical analysis 
Results are presented as mean and percentages. Data were analyzed with 
SPSS 15.0. 
RESULTS  
Gynaecological findings 
A total of 101 fertile women were enrolled in this study, mean age 34 years 
(range 22-51 years). Eighteen patients (18%) were referred by their General 
Practitioner, and 83 (82%) were referred for second opinion by 
gynaecologists. Patients presented a wide range of gynaecological 
complains: dysmenorrhoea 87 (86%), deep dyspareunia 42 (42%), dyschezia 
30 (30%), cyclic rectal bleeding 9(9%), dysuria 14 (14%) and hematuria 3 
(3%). Subfertility was found in 48 (47.8%) women. Twelve (11.9%) patients 
were known to have first-degree relatives with endometriosis. 
Endometriosis was diagnosed in 98 (97%) patients by laparoscopy or 
laparotomy in 77 (76%) and 21 (21%), respectively. In 3 (3%) patients 
endometriosis was detected visually in the vaginal wall. Endometriosis of the 
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ovaries was most frequently diagnosed (68%), followed by endometriosis in 
the pouch of Douglas (13%).  
Rectosigmoidal localization was diagnosed in 9% of the women. Vaginal 
endometriosis lesions were found in 3% of the patients. Urological and 
multiorgan disease were encountered in 2% and in 11% of the patients, 
respectively.  
The median time elapsed from onset of the symptoms until diagnosis of 
endometriosis was 2.8 years (range 0.5-11years) (figure 1). 
 
 
Figure 1. Time to diagnosis of endometriosis. 
Gynaecological treatment 
During initial evaluation the following hormonal treatments for endometriosis 
were used: oral contraceptive pills (OCs) in 37 patients (37%), progestins in 8 
patients (8%), levonogestrel-releasing intrauterine device (IUD) in 6 patients 
(6%), luteinizing hormone-releasing hormone (LHRH) - analogues in 28 (28%), 
respectively. Twenty-two (22%) patients were without hormonal treatment 
at the time of inclusion.  
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Gastroenterological findings 
Fifteen (15%) women had additional IBS symptoms: 9 (9%) with constipation, 
2 (2%) with diarrhea, 2 (2%) mixed type or unsubtyped. Furthermore, 14 
(14%) women had functional constipation without IBS. Both patients with IBS 
and with constipation reported in 80% exacerbation of their symptoms 
during menses.  
 
Gastroenterological treatment 
Of the 29 patients with IBS or constipation 22 (76%) agreed to a 
gastroenterological referral (figure 2). In five patients bowel stenosis due to 
endometriosis was found. Subsequently they underwent surgical resection 
of the involved bowel segment with primary anastomosis.  
Postoperatively, four out of five patients improved clinically and had no 
residual symptoms. One patient was readmitted 6 weeks after the surgery 
with an ileus due to stenosis of the anastomosis which was successfully 
endoscopically dilated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Patients referred to the gastroenterologist. 
29 patients with IBS or constipation 
22 seen by gastroenterologist 
5 surgery 
1 improved after 
further dilatation 
of anastomosis 
17 conservative 
1 refused 
5 improved 
defecation,  
but not pain 
2 not improved 
9 improved 
defecation and pain 
4 improved 
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Seventeen of the referred patients were treated conservatively with 
laxatives and fibre (table 3). In 14 patients (64%) defecation improved after 
treatment through the time of follow-up, 2 women in spite of treatment had 
no improvement of the complains, 1 of them refused further any other 
treatment. In 9 patients there was additional relief of pain. Thus of all 
referred patients, in 19 out of 22 (86%) defecation improved and pain in 14 
out of 22 (64%).  
 
Table 3. Improvement of symptoms in 17 patients after treatment with fibre 
supplementation. 
 
DISCUSSION 
The etiology of endometriosis is not yet fully understood, but it is generally 
accepted that retrograde menstruation is the key component in 
development of endometriosis. Numerous epidemiological studies have 
shown that women with early menarche, short and heavy menstrual cycles 
are at increased risk of developing endometriosis. These epidemiological 
findings strongly support the menstrual reflux hypothesis 2,6.  
The etiology of endometriosis is multifactorial and polygenic which explains 
the 5-8% risk for first-degree relatives to be affected 6-8. In our study however, 
endometriosis in first-degree relatives was found in 12%. Although this is an 
 initial complaints improved  unaltered 
Straining during at least 25%  of defecations 7 6 1 
Lumpy or hard stools in at least 25%  of defecations 13 10 3 
Sensation of incomplete evacuation for at least 25%  of 
defecations 
4 3 1 
Manual manoeuvres to facilitate at least 25% of 
defecations 
2 1 1 
Fewer than  3 defecations per week 14 10 4 
Pain 14 9 5 
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higher prevalence with respect to earlier reports 6-8, it is uncertain whether it 
reflects a stronger genetic expression for this disease in our population as no 
genetic data were collected.  
Although the ectopic endometriotic implants are usually found on the 
internal genital organs, the gastrointestinal tract, in particular the 
rectosigmoid colon, is the most common site of extragenital endometriosis. 
The estimated incidence of intestinal endometriosis is between 5.3% and 
12% among women with endometriosis 9,10. In expert centers, its incidence 
may reach up to 35% among patients with deep pelvic endometriosis 11. 
The most frequent location of bowel endometrosis is the rectosigmoid (93%), 
followed by appendix, ileum and caecum 10,12. The prevalence of bowel 
endometriosis in our study was 9%, which is in line with previous reports 9,10. In 
five patients endometriosis caused a largely restricted bowel lumen in 
which bowel function was greatly impaired. Resection of the obstructed 
bowel to achieve bowel continuity was performed with good result. Our 
results are consistent with several other studies demonstrating significant 
postoperative improvement of digestive symptoms as well as quality of live 
in this subset of patients 12. 
Up-to-now a considerable delay between symptoms onset and a definitive 
diagnosis of endometriosis is reported. Women are often treated for other 
assumed disorders before endometriosis is established 1,6. 
Some studies show a delay of up to 12 years 13-15. In our study the average 
time between first symptoms and a correct diagnosis was 2.8 years (figure 
1). This may be related to the fact that the majority of included patients in 
this prospective study had a severe form of endometriosis with distinct 
symptoms. In addition, an increasing awareness of endometriosis in the 
general population as a result of extensive information available on internet 
and through patients’ associations may contribute in this finding. Moreover, 
general practitioners in the Netherlands may have undergone an increased 
awareness on endometriosis which may result in an accelerated referral to 
specialists.  
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Pharmacological management of endometriosis depends on the extension 
and severity of disease, the age of the patient and whether there is desire 
for pregnancy. Our patients had a very extended, severe form of 
endometriosis, where treatment with GnRH-agonists often is needed 12. 
There are still new approaches to pharmacological therapy of 
endometriosis, including the levonorgestrel-releasing intrauterine device 
(LNG-IUD), aromatase inhibitors, immunomodulatory drugs and 
angiogenesis inhibitors 6.  
In our study, most women were treated with OCs (36.6%) and LHRH 
analogues (27.7%). Only 8% were treated with progestins and 6% with a 
LNG-IUD.  
IBS and chronic pelvic pain affect a large population of women 16 and are 
associated with increased health care use 17 and decreased quality of  
life 17.  
Most patients with endometriosis will experience the classic pelvic 
endometriosis triad of dysmenorrhoea, deep dyspareunia and dyschezia. 
Digestive complains such as diarrhea and/or constipation, cramping and 
rectal bleeding are reported in respectively 15%, 26% and 33% of the 
patients 18. The cyclic exacerbation of those symptoms associated with 
menstruation is often found. These complaints largely overlap with those 
found in patients with IBS (table 1) and visa versa. In our study this 
phenomena was found in 80% of the patients with IBS. This may be 
explained by earlier observations suggesting that increased levels of 
prostaglandins during menstrual phase may exurb IBS symptoms 19,20. 
The prevalence of IBS is approximately 32% in women with endometriosis 
without bowel lesions 21.  
The prevalence of chronic constipation is estimated at 12-19% 22.  
In our study similar results were obtained; 15% of the patients had also IBS 
symptoms, and in 14% functional constipation.  
For patients with IBS and constipation, fibre supplementation may improve 
symptoms of constipation, although abdominal pain is unlikely to  
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change 23,24. Our results show that in 14 (64%) of the 22 patients presented to 
the gastroenterologist symptoms improved after treatment with bulk-formers 
and/or laxatives. The 5 patients with a significant stenosis were treated with 
a local resection of the involved rectosigmoid which induced improvement. 
Of the 17 patients without stenosis, 14 (82%) had improvement of 
defecation complains. Pain also improved in 64%. However, improvement 
did not mean pain free, but a decrease of pain more than 50%. This limited 
response is a well-recognized problem and might be due to  involvement of 
the nervous system, immune cells and inflammatory response to pain 
caused by endometriosis. For many women with endometriosis 
management of pain is still insufficient 25. This observation is consistent with 
our results, where five of the twelve patients after treatment with fibres and 
laxatives still had abdominal pain after adequate regulation of defecation. 
It is obvious that treatment of endometriosis and IBS should be individualized 
according to the therapeutic goals, the extension of disease, symptoms 
and age of the patient. 
In conclusion, gastroenterological and gynecological symptoms of 
endometriosis often coexist. In patients with a stenosis of rectosigmoid, local 
resection leads to improvement of defecation and pain. In patients without 
bowel stenosis, conservative treatment improved defecation in 86% and 
pain is decreased in 64% of the patients. Therefore, gastroenterologists and 
gynaecologists should collaborate in the treatment of endometriosis to 
evaluate overlapping symptoms so that neither accurate diagnosis is 
missed nor right treatment is delayed. 
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Abstract        
The incidence and therefore complications of (sigmoid) diverticular disease 
are increasing. Of all patients, 15% will develop diverticulitis, 5% 
complications and 5% diverticular bleeding.  
Diagnosis is established with CT. Colonoscopy needs to rule out malignancy. 
NSAID’s increase the risk of perforation; steroids, diabetes, collagen vascular 
disease and immune compromized are associated with complicated 
disease and death.  
In mild diverticulitis antibiotics are recommended. In complicated disease 
with abscesses < 5 cm antibiotics are sufficient. Larger abscesses are 
drained under CT-guidance. Peritonitis forms an indication for surgery.  
Diverticulitis recurrence rate is around 30%, most are uncomplicated. 
Recurrence after surgery is around 10%.  
Elective surgery is reserved for fistula closure and obstruction. The need for 
elective surgery to prevent recurrence has diminished due to new insights. 
Important is to identify risk groups. New issues are the possible relationship 
between diverticulitis and cancer, segmental colitis associated with 
diverticulitis (SCAD), and treatment of diverticulitis with mesazaline and 
probiotics. 
In summary, uncomplicated diverticulitis is treated medically. Complicated 
diverticulitis with small abscesses is treated with antibiotics while larger 
abscesses are drained with CT-guided puncture. Emergency surgery is 
reserved for peritonitis, elective surgery for fistula/stenosis. Surgery to prevent 
recurrence is only indicated in selected cases (immune compromised e.g.) 
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INTRODUCTION  
Diverticulosis and therefore diverticulitis are increasing, what consequently 
increases complication rate. The prevalence of perforated sigmoid in 
diverticular disease in the western countries has increased from 2.4/100.000 
in 1986 to 3.8/100.000 in 2000 1. Another distressing factor is that during the 
last 20 years, standardized annual age rates of admission and surgical 
intervention have increased by 16% from 20.1/100.00 to 23.2/100.000, 
whereas inpatient and population mortality remained unchanged 2.  
The terminology of diverticular associated disease needs to be used 
adequately in order to avoid confusion3 (table 1). 
 
 
Diverticulosis: 
 
presence of diverticula that are asymptomatic 
 
Diverticular disease: diverticula associated with symptoms  
 
Diverticulitis: evidence of diverticular inflammation (fever, tachycardia) 
with or  without localised symptoms or signs       
 
Complicated 
diverticulitis: 
perforation (into peritoneal cavity), abscess, fistula,  
stricture/obstruction    
   
 
Table 1. Terminology of diverticulosis 
 
Diverticulosis 
Anatomy 
The diverticula of diverticulosis are false diverticula, due to pulsion of 
herniating mucosa and submucosa through the muscle layer. This is contrast 
to the congenital diverticula, which contain all bowel layers. Diverticula 
tend to occur at 4 points around the circumference of the colon where the 
vasa rectae penetrate the circular muscle: each side of the mesenteric 
taenia, and on the mesenteric border of the 2 antimesenteric taenia 4. 
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Epidemiology 
Although diverticulosis was noticed in the 19th century, the Mayo brothers 
reported the first operation for diverticular disease in the United States in 
1907 5. The prevalence of diverticulosis in the US in the early 20th century 
was reported as 5% to 10% 6. In 1969 autopsy series reported 10% to 66% 
presence, depending on age 7. There is an increase in the prevalence of 
diverticulosis with age, from less than 10% in those under the age of 40 to 
50%-70% among those over the age of 70 8-10. There is no clear overall 
difference in prevalence between women and men. Diverticula are 
located in 95% in the sigmoid, in 35% additionally also proximal, 7% are 
pancolonic 11. There seems also to be a striking geographical variation in 
the prevalence of diverticulosis, since Asian nations report much lower 
prevalences 6,12. One differential aspect between diverticular disease in the 
West and Asia is the predominant right location in the latter. A right colon 
location was observed in 83% of patients, whereas only 17% had lesions 
located exclusively in the left colon 13. However recently, due to decreased 
fiber intake, both an increase in right-sided diverticulosis as well as an 
increase in left-sided diverticulosis has been observed in developing Asian 
countries 14. 
Pathophysiology 
The pathophysiology is related to a low fiber diet, altered motility and 
colonic wall resistance. 
The major hypothesis concerning the propensity to form diverticula focuses 
on dietary fiber 9,13,15. Most studies support a strong inverse relationship 
between population fiber intake and the prevalence of diverticulosis. One 
study of approximately 47,000 men found a relative risk of 0.58 for the 
presence of diverticulosis comparing the quintile with the highest average 
fiber intake with the quintile with the lowest intake 15. Diverticulosis seems to 
become more common among groups that move to western countries or 
that adopt a western-style diet 16. Moreover, other studies have also pointed 
to the fact that diverticulosis seems to be less common among   
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vegetarians 17. The role of fiber in the pathogenesis of diverticulosis likely 
rests on its influence on colonic pressures. The inverse relationship between 
colonic diameter and pressure is explained by the Law of Laplace, in which 
P=kT/R (where P is the pressure, k is a constant, T is the wall tension, and R is 
the bowel radius). Fiber may mediate the generation of lower pressures in 
the sigmoid colon by increasing the bulk of stool; bulkier stools may 
discourage segmentation and increase the diameter of the sigmoid colon, 
resulting in lower pressures. Furthermore, the decrease in soluble fiber may 
also have important physiologic effects, altering gut flora in particular, 
which may have significant immune consequences central to the 
pathophysiology of diverticulitis 18. 
Motility seems to play an important role. Most manometric studies indicate 
that patients with diverticula have higher resting pressures and postprandial 
colonic pressures than controls 10,19. However, normal pressures have been 
found in another study 20. More recent study showed that in early disease 
high pressures and irregular slow waves can be found, but that in late 
disease these features have normalized 21. In addition, diverticular colon has 
exaggerated segmentation 22. Segmentation leads to high pressure, which 
is the highest in the part of the colon with the smallest diameter, the sigmoid 
colon, which is the part most often involved by diverticulosis. Furthermore, 
interstitial cells of Cajal and glial cells are decreased in colonic diverticular 
disease, whereas enteric neurons appear to be normally represented. This 
finding might explain some of the large bowel motor abnormalities reported 
to occur in this condition 23. 
Another aspect is the colonic wall resistance. The structure of colons with 
diverticula is often marked by myochosis, with thickened circular muscle, 
shortened taenia, and narrow lumens. On a microscopic level, colons with 
diverticulosis may have increased elastin in the taenia 24 and structural 
changes in collagen that mimic those seen with aging 25. This concerns not 
so much the total amount of collagen, but the cross linking and an increase 
in type 3 fibers 19,26. The involvement of these changes in the development 
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of diverticulosis is supported by the observation that diverticulosis tends to 
occur at younger age in patients with connective tissue diseases such as 
Ehlers-Danlos or Marfans syndromes 26. 
 
Relationship with diverticulitis 
Among patients with diverticulosis, approximately 70% will remain free of 
major diverticular complaints. Some patients with diverticulosis will complain 
of a variety of vague symptoms, including cramping, bloating, flatulence, 
or irregular defecation (diverticular disease); of these, many likely have 
irritable bowel syndrome. Approximately 15% to 25% of patients with 
diverticulosis will develop diverticulitis, and 5% to 15% will develop 
diverticular bleeding. Among patients with diverticulitis, approximately 75% 
will have simple diverticulitis and 25% will have diverticulitis complicated by 
abscess, obstruction, perforation, or fistula formation. 
The only intervention with evidence to suggest that it reduces risk of 
diverticular disease and its complications is a high fiber diet, which may 
reduce the risk of developing diverticular disease 15,27 and may also reduce 
the risk of later complications among patients with diverticulosis 9. 
 
Diverticular disease 
Some patients with diverticulosis reports recurrent colicky abdominal pain, 
and/or changed bowel habits without any findings consistent with 
diverticulitis, which has been called uncomplicated symptomatic 
diverticulosis. Occurances of abdominal pain in these patients may be 
related to abnormal colon motility. In a controlled study, episodes of 
cramping abdominal pain were coincident with a regular colonic 
contractile pattern, as assessed by 24-hour colonic manometry 23. 
Considering the high prevalence of irritable bowel syndrome (IBS) (5-25%) 
and diverticulosis (10-66%), both conditions may coexist frequently 10,28.  
One study showed heightened visceral perception of the rectosigmoid (not 
only in the area with diverticula), not due to altered compliance of the 
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bowel wall 29. This situation of hyperperception resembles IBS. In a 
community-based survey, a study of 261 patients with diverticulosis 
diagnosed by barium enema, observed that 14% met the Rome I criteria for 
IBS, 36% had recurrent short-lived pain, and 19% had episodes of prolonged 
pain lasting for 1 day or longer, which in more than 60% required 
emergency medical attention 30. In more than half of the patients with 
prolonged pain, there was also short-lived pain as part of their usual bowel 
habit. The authors concluded that recurrent short-lived pain (similar to that 
seen in IBS) often occurs in patients who have experienced prolonged pain 
attributable to diverticulitis. However, the presence of colonic diverticula 
does not seem to change the natural history of IBS 28. The connection 
and/or differences between uncomplicated symptomatic diverticulosis and 
IBS should be further clarified in future studies. Treatment with a high-fiber 
diet is recommended for patients with symptomatic uncomplicated  
diverticulosis 10. 
Although there is theoretically no rationale for the use of antibiotics in this 
group of patients, this has been performed. Three Italian randomized trials 
comparing daily fiber supplementation alone or with cyclic administration 
of oral rifaximin for 12 months in 168 and 968 patients 31,32 or 24 months in 307 
patients 33 showed that significantly more patients in the rifaximin group 
were free of symptoms, and in one of the studies the incidence of 
complications (mainly diverticulitis) was also reduced. Although the 
mechanism for such improvement is unknown, the authors postulate that it 
could be related to a reduction in gas production and bacterial 
overgrowth.  
The same applies for the use of mesalazine in several Italian studies. In 
recent large study of 286 patients, who were randomized treated ten days 
a month with either rifaximine (200 or 400 mg twice a day) or Mesazaline 
(400 or 800 mg twice a day), the patients treated with mesazaline improved 
more on a global symptom score 34. Daily prescription may even be more 
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effective 35. Reduction of inflammation due to altered bacterial flora is 
thought to play a role. 
In an attempt to alter the bacterial microflora two open label prospective 
studies have been conducted with probiotics. One study contained 90 
patients where Lactobacillus casei, mesazaline or both were given for 15 
days a month. Given separately, 76% was symptom free and the patients 
who received the combination became in 95% symptom free after one 
year 36. Another study compared an intestinal antimicrobial 
(dichlorchinolinol) and absorbent (active coal tablets) with the same set-up 
supplemented with non-pathogenic Escherichia coli in a prospective open 
trial in 15 patients administered for 1 and 5 weeks. The non-pathogenic 
Escherichia coli significantly prolonged the symptomatic remission period 
(14 and 2,4 months) 37.  
 
Diverticulitis 
Pathogenesis 
Diverticulitis refers to a spectrum of diverticular disease ranging from 
subclinical inflammation to generalized peritonitis. The pathology of 
diverticulitis is characterized by inflammation and focal necrosis of 
diverticula leading to micro- or macroscopic perforation of a diverticulum. 
Most small perforations are walled off, although some will lead to abscess or 
fistula formation. The inciting agent of the inflammation was earlier thought 
to be fecoliths that obstructed diverticular lumens; this, however, turns out 
to be rare. The main culprit seems to be inspissated food that leads to 
mucus secretion and eventual bacterial overgrowth within the diverticulum. 
Symptoms 
The classic presentation of diverticulitis in the western world includes left 
lower quadrant abdominal pain and tenderness, constipation, fever and 
leukocytosis. However, the clinical features can be quite variable. 
Approximately 85% of diverticulitis involves the sigmoid/descending colon. 
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Seventy percent of patients present with left lower quadrant pain and 25-
50% of patients will report having had previous episodes of diverticulitis. 
Although constipation is present in 50% of patients, 25% to 35% of patients 
may present with diarrhea, 20% to 62% may have nausea and vomiting and 
10% to 15% may describe urinary symptoms 38. Abdominal tenderness is 
present in most patients, and approximately 20% will have a tender mass 
palpable on exam 8. Low-grade fever and leukocytosis are also 
characteristic, but 45% of patients will have a normal white blood cell  
count 39. The presention is particularly apt to be atypical among patients 
with conditions such as HIV infection, organ transplantation or cancer, in 
which immunosuppression is common 40,41. 
Not surprisingly, given the variable presentation of diverticulitis and the 
spatial relationship of the colon to other intraabdominal organs, the 
differential diagnosis for diverticulitis is broad. Potential diagnostic 
considerations might include appendicitis, Crohn’s disease, colon cancer, 
ischaemic colitis, pseudomembranous colitis, complicated ulcer disease, 
ovarian cyst or torsion, or ectopic pregnancy. Nonetheless, the diagnosis is 
often relatively clear among those patients presenting with typical features. 
Diagnosis 
The diagnosis of diverticulitis is usually suggested by history and clinical 
exam. Various adjunctive tests, such as abdominal and chest x-ray, 
compression ultrasonography and single contrast barium enema have 
been and are used, although enema examinations are not much used 
anymore. Increasingly, computed tomography (CT) scans are the test of 
choice to confirm a clinical suspicion of diverticulitis. The literature has 
reported excellent test performance characteristics for CT scans, with 
sensitivity as high as 97% and specificity of up to 100% 42. Findings on CT 
scans include soft tissue density in pericolic fat (present in 98%), the 
presence of colonic diverticula (present in 84%), bowel wall thickening 
greater than 4 mm (present in 70%), phlegmon and pericolic fluid (present 
in 35%) 43,44. However, CT findings alone are insufficient to exclude cancer in 
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approximately 10% of cases 45. Therefore, patients who have not had a 
colonoscopy yet should have one after resolution of the disease. CT has 
additional advantages of permitting classification into mild and severe 
categories, which may aid in predicting success of conservative therapy 46 
and in selecting patients for surgery 47,48. Diverticulitis may be complicated 
by abscess and fistula formation, peritonitis, or obstruction. CT may help 
differentiate abscesses that require drainage versus those that can be 
managed conservative and that behave like uncomplicated diverticulitis; 
the suggested size cut-off for such a distinction is 5 cm, with smaller abscess 
generally responding to medical treatment without drainage.  
Treatment 
The treatment of diverticulitis depends on the severity and extent of disease. 
Recommendations are available from some of the professional societies, 
such as the American College of Gastroenterology and the American 
Society of Colon and Rectal Surgeons. Many other countries conform 
themselves to these general guidelines with certain exceptions.   
Patients (70% to 100%) with simple, uncomplicated diverticulitis will improve 
with conservative measures. Bed rest, only clear liquids or total dietary 
restriction are the first step. Antibiotics are usually, but not always given. A 
recent study questions the routine use of antibiotics 49. Antibiotics are 
generally chosen to cover Gram negative rods and anaerobes; for 
example a combination of ciprofloxacin and metronidazole 50-52. CT scans 
may be useful for predicting success of conservative therapy 48,53. A critical 
decision is whether to hospitalise a patient; this decision may rest on such 
features as disease severity, ability to tolerate oral intake, age, comorbidity 
and availability of adequate support systems at home.  
Complicated disease demands a more intense approach. One commonly 
used system to group patients according to severity of disease is the Hinchy 
classification 54 (table 2). Patients with abscesses larger than 5 cm usually 
require CT-guided abscess drainage. In cases of peritonitis (Hinchy 3 and 4) 
emergency surgery is required, where cleansing of the peritoneal cavity 
                                                                                                                                              
  83  
and a sigmoid resection with an end-to-end procedure is preferable. 
Peritonitis carries a high mortality rate of approximately 6% if purulent and 
35% if faecal. Fistula will be electively operated, as will patients with 
obstruction where malignancy cannot be excluded with colonoscopy. 
 
Stage 1     Pericolic or mesenteric abscess 
Stage 2     Walled –off or pelvic abscess 
Stage 3     Generalized purulent peritonitis 
Stage 4     Generalized faecal peritonitis 
 
Table 2.  Hinchy classification of peritoneal contamination of diverticulitis 
Prognosis 
The prognosis of diverticulitis after resolution of the acute symptoms is 
generally good. Approximately 30% to 40% of patients will remain 
asymptomatic, 30% to 40% will have episodic cramps without clinical 
evidence of recurrent diverticulitis and 30% will have recurrent  
diverticulitis 8,10,12,51. In the past, Parks stated that recurrent attacks of 
diverticulitis had a high likelihood of being complicated and to be 
associated with higher mortality than initial attacks 8. Furthermore, 
guidelines for elective surgery to prevent recurrent attacks were derived 
from the Parks study and newer studies were not included in these 
guidelines yet 55. The older studies did not account for better medical care 
and new therapeutic options like CT- drainage. However, more recently it 
appears that recurrent attacks occur less frequently and with similar 
likelihood of complications as initial attacks 10,55,56. Moreover, only about 25% 
of people with complicated diverticulitis have a previous attack, thus 
making prevention even more difficult 57-59. Among patients who undergo 
surgery for diverticulitis, 15% will develop diverticula in the remaining  
colon 60, approximately 2% to 11% will need further surgery 60,61, and up to 
27% will have postoperative pain in the same location.  
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Elective surgery for whom? 
Indications for elective surgery remain controversial, particularly for 
uncomplicated diverticulitis. In view of the recent literature, a more 
nuancated approach may be appropriate. It seems that some subgroups 
are at risk for complicated disease. These are the patients with co-
morbidity, like diabetes mellitus, collagenous disease and the immune 
compromised 55,60,61. Also the concept that younger (male) patients are at 
high risk for complicated (recurrent) diverticular disease merits more critical 
re-appraisal. Older studies suggested indeed a higher risk in these  
patients 27,51,62-65, but newer studies have shown that establishing the correct 
diagnosis was delayed because it was not suspected. Moreover, there was 
a striking percentage of obesitas masking the symptoms in these patients 66. 
The recurrence and complication rate were not higher then in elderly 
patients 67-74. Adipositas itself forms a risk factor for diverticulitis. They have 
not only an increased risk to develop diverticulitis 66, but also experience 
more complications 75. Obese patients have an increased mortality rate of 
5.2 76 and require a longer operation time and more post operative 
analgesics 77. Thus suggested by some authors resection after 2 or after 3 
episodes of uncomplicated diverticulitis therefore needs to be re-
considered and should be limited to patients at risk with co-morbity like 
diabetes, collagenous disease and the immune compromised patient. 
 
New Issues  
Segmental colitis associated diverticulitis (SCAD) 
This is defined as chronic mucosal inflammation of the sigmoid colon 
bearing diverticula with rectal spearing. The clinical presentation consists of 
rectal bleeding, occasionally left-sided abdominal pain and less frequently, 
bowel alterations. The endoscopic features are those of sigmoiditis 
(erythema, congestion and contact bleeding) with rectal sparing. The 
orifices of diverticula may or may not be involved. The histological  
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changes 78 are mostly similar to those detectable in inflammatory bowel 
disease (IBD): cryptic abscesses with crypt distortion, mononuclear cell 
infiltrate, lymphoid aggregation, epithelial cell sloughing 79 and sometimes 
granulomata 80,81. On the whole, the histopathological features and rectal 
sparing mimic the picture of Crohn's disease rather than that of ulcerative 
colitis. In fact, in ulcerative colitis even when the rectum is endoscopically 
spared, histological involvement is always present 82. 
Is segmental colitis a distinct clinical entity or coexistence of sigmoid 
diverticulosis and IBD? Both diverticulosis and segmental colitis usually affect 
elderly patients, especially men. It is also known that IBD presents a second 
peak of incidence in the population over the age of 60 83. The incidence of 
segmental colitis is estimated to be 0.3–3.8% 80,84-86. The results above are too 
small to allow definitive conclusions to be made in terms of epidemiology.  
To add to the confusion, in about 10% of cases of segmental colitis, 
inflammation subsequently spreads to the rectum, even when this was 
initially histological normal, making it impossible to distinguish this condition 
from ulcerative colitis 80,84. On the other hand, even when the rectum 
remains uninvolved and concomitant Crohn's colitis can be suspected, 
perianal disease is always absent 80,87. In segmental colitis, unlike in Crohn's 
colitis, symptoms such as nausea, vomiting, weight loss and fever are never 
present and laboratory findings are usually normal, the acute-phase 
reactants and/or white cell count are rarely increased 85,87. When 
segmental colitis is considered a distinct disorder, what are the possible 
causes of local inflammation? A role for bacterial flora promoted by faecal 
stasis has been postulated 87,88. Other postulated factors are increased 
permeability to intraluminal antigens 87, focal ischaemia due to impairment 
of local microcirculation 89 and enhanced local production of nitric oxide 
and oxygen-reactive radicals 87. 
Medical treatment of segmental colitis is empirical and usually carried out, 
in addition to a high-fibre diet, by the same pharmacological agents 
employed in the treatment of IBD, i.e. sulfasalazine, Mesazaline and 
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occasionally antibiotics 84,79. The majority of cases are responsive to such 
medications 79,84,90, immunosuppressive medication is rarely required. Again, 
this differs from IBD in which steroids and immunosuppressants are often 
necessary. Patients with segmental colitis rarely require surgery 79,89 and in 
contrary to patients with Crohn's colitis, they seldom experience post-
operative recurrences 81,91.  
A differential diagnosis with IBD is important in order to optimise the 
treatment and long-term management of the disease. To that purpose the 
diagnostic workout should include accurate evaluation of the small bowel 
by means of ileocolonoscopy with mucosal biopsies, and or other imaging 
techniques. 
 
Diverticular disease and cancer 
Some studies have suggested the relationship between diverticulitis and 
colon cancer. In 1979 an association in 42 patients with diverticulitis in a 
group of 385 cases of colonic cancer was found 92. In a retrospective study 
of a group of 150 patients in 1988 and 630 patients in 2002, there was a 
higher incidence of advanced adenomas in the sigmoid colon in patients 
with diverticular disease. Nevertheless, there was no higher prevalence of 
colorectal cancer in patients with diverticula in comparison to those  
without 93,94. 
In a study with 7159 patients, a significantly long-term increased risk of left-
sided colon cancer in patients with diverticulitis compared to those with 
only diverticulosis was found 95. In contrast, a study with 512 patients with 
colonic resection due to diverticulitis showed a statistically significant 
decreased rate of advanced colonic neoplastic lesion in all age groups, 
but no relation with adenocarcinoma 96. 
Laboratory tests are contradictory. A study in patients with diverticular 
disease demonstrated that hyperproliferation of the colonic mucosa was 
localized in the upper third of the colonic crypts 97. This hyperproliferation of 
the colonic mucosa was detectable in the whole length of the colonic 
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crypts in the patients not only with symptomatic diverticulosis and acute 
diverticulitis but also in patients with asymptomatic diverticulosis 98.  This 
suggests that not only patients with acute diverticulitis but also those with 
asymptomatic diverticulosis may be at a risk of developing adenomas and 
colonic carcinomas. In contrast, a different matrix microenvironment was 
found between the colonic tissue architecture of the patients with colon 
cancer and those with diverticular disease, thus implying no predisposition 
for cancer in diverticular disease 99. Although this is different from overt 
diverticulitis. 
One of the feasible explanations for the association between diverticular 
disease and colorectal cancer is that the presence of an inflammation 
process increases the risk for a malignant transformation 100, since in the 
western population diverticular disease occurs usually in the left colon. 
 
CONCLUSION 
Diverticulosis and diverticulitis are emerging diseases. Prevention is an 
important factor and therefore a fibre enriched diet should be 
encouraged. When diverticulitis develops, uncomplicated disease can be 
managed conservatively. Even abscesses smaller than 5 cm can be 
managed with bed rest, dietary restrictions and antibiotics. Larger 
abscesses are punctured under CT guidance. The more serious 
complications require emergency surgery. New insights have shown that 
elective surgery to prevent recurrence should be reserved for patients at risk 
(co-morbidly, e.g. immune compromised). Not youth, but obesity is a risk 
factor for complicated disease. New therapies like mesazaline, rifaximin and 
probiotics merit more attention in prevention of diverticular disease and 
diverticulitis. Relationship with inflammatory bowel disease (SCAD) and 
sigmoid carcinoma needs further evaluation. 
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Abstract 
Background and aim 
There are conflicting data concerning the association between diverticular 
disease and colorectal carcinoma (CRC). This study was performed to 
determine the prevalence and association of diverticulosis, diverticulitis, 
polyps, and CRC.  
Materials and methods   
In a cross-sectional, retrospective study, we analyzed the colonoscopy 
reports of complete colonoscopies and patho-histological results of all 
patients referred for colonoscopy in a period of 3 months in 18 hospitals in 
the Netherlands. Diverticulosis was defined as three or more diverticula 
present and diverticulitis as diverticulosis with inflammation. Polyps were also 
coded according to localization and size. Advanced neoplastic lesions 
were defined as polyps ≥10 mm in diameter and/or villous architecture 
and/or adenomas with high grade dysplasia and/or invasive cancer. 
Actual and previous described CRC were registered.  
Results   
A total of 4,241 patients were included in the study [1,996 (47%) male], 
mean age of 59 and range 18–95. Diverticula, diverticulitis, and polyps were 
seen in 1,052 (25%), 75 (2%), and 1,282 (30%) patients, respectively. No 
association was found between patients with polyps and those with and 
without diverticulosis (p=0.478). Invasive adenocarcinoma and adenomas 
≥10 mm were most frequently observed. CRC was present in 372 (9%) 
patients. Negative relation between diverticulosis and CRC and invasive 
adenocarcinoma was observed. No association was found between polyps 
and CRC and patients with diverticulitis and CRC. In conclusion, there is no 
relation between patients with diverticulosis and higher incidence of polyps 
or CRC when using age-stratified analysis. No increased risk for polyps or 
CRC was found in patients with diverticulitis.  
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INTRODUCTION 
The prevalence of diverticulosis and subsequently diverticulitis is increasing 
in the last decades 1,2. Diverticulosis increases with age; it is estimated less 
than 10% in those under the age of 40 and increases to 65–70% in those 
above 65 years of age 3-5. Besides diverticulosis, the prevalence of colon 
cancer is also increasing in the western world 3,6. Colorectal cancer is a 
leading cause of cancer mortality in the western world, with more than 
1,000,000 new cases per year and with 500,000 deaths per year worldwide 7. 
The estimated lifetime risk is 5–6%, where incidence rates increase sharply 
after the age of 50 years 8. In the Netherlands, colorectal cancer is 
diagnosed in about 10,000 patients each year and causes 4,400 deaths per 
year 9,10. Colorectal cancer is the third most common cancer in men and 
the second commonest in women in this country. Certain groups are at risk, 
like autosomal dominant syndromes, familial adenomatous polyposis, 
hereditary non-polyposis colorectal cancer (HNPCC), Peutz–Jegher’s 
syndrome, acromegaly, and Gardner syndrome 11,12. Patients who are at risk 
are included in colonosopic surveillance programs 13,14.  
The relationship of diverticulosis, diverticulitis, colon polyps, and the 
occurrence of cancer is complicated and conflicting. There are studies in 
patients with diverticulosis that found an increased incidence of polyps 1,15,16 
and colorectal carcinoma (CRC) 17,18, a decreased incidence of polyps 19 
and colon carcinoma 1,19, or no difference in CRC 20. In patients with 
diverticulitis, an increased 21 and decreased risk 19 for CRC was described. 
When diverticulosis and diverticulitis form an increased risk for CRC, a 
different view concerning colorectal screening should be taken.  
The aim of this study was to establish the relationship between diverticulosis, 
diverticulitis, polyps, advanced neoplastic lesions (ANL), and colon 
carcinoma in a retrospective, cross-sectional study. 
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Materials and methods 
Patients 
In a 3-month period from September to November 2006, 4,241 outpatients 
who underwent colonoscopy in 18 hospitals in the region of North Holland 
were included. Of all the hospitals which took a part in our study, 17 were 
peripheral hospitals and 1 was tertiary clinic (our hospital).  
The indications for colonoscopy included uncomplicated lower abdominal 
pain of at least 2 months’ duration, hematochezia, gastrointestinal 
hemorrhage, unexplained changes in bowel habit, weight loss, iron-
deficiency anemia, chronic obstipation without positive reaction on the 
treatment, chronic diarrhea, surveillance after colonic polypectomy, and 
screening for and follow-up of colorectal cancer. Permission was granted 
from the central medical ethics review board of the VUMC medical center.  
 
Methods 
The reports of 3 months complete colonoscopies and pathohistological 
results were entered in a database coding for age, sex, indication, medical 
history as present, endoscopic findings like inflammation, diverticula, polyps, 
CRC, and pathohistological results. Diverticulosis was defined as three or 
more diverticula present. Diverticulosis with inflammation was coded as 
diverticulitis. Any detected polyp was coded separately according to 
localization and size. Any described or earlier diagnosed macroscopic CRC 
was coded as CRC. ANL were defined as an adenomas ≥10 mm or more in 
diameter, >25% villous architecture and/or adenomas with a high-grade 
dysplasia and/or an invasive cancer. Benign polyps were defined as 
hyperplastic polyps and adenomas <10 mm with low/intermediate grade 
dysplasia.  
 
Statistical analysis 
The frequency, location, and size of polyps are described in patients with 
diverticulosis and diverticulitis as well as frequency of colorectal cancer. 
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Results are presented as mean and SD; statistical testing was done with the 
chi-square test, when appropriate corrected for age with the Mantel–
Haenszel test (age stratified analysis in 10 years classes). Calculations were 
made with the SPSS program (SPSS 14.0).  
 
RESULTS 
A total of 4,241 patients were included in the study [1,996 (47%) male and 
2,245 (53%) female], mean age of 59 and range 18–95. Patients with 
diverticulosis, polyps, and cancer were significant older than those without: 
mean age 69 vs. 56, 64 vs. 57, 68 vs. 58, respectively, p<0.0001. Diverticula 
were seen in 1,052 (25%), diverticulitis in 75 (2%), polyps in 1,282 (30%), and 
CRC in 372 (9%) patients.  
In 98% of the patients, predominantly left-sided diverticulosis was found. In 
21 (2%) patients, mainly right-sided diverticula were seen. The mean age of 
the patients with diverticular disease was 69.5 (SD 11.8) as compared with 
55.9 (SD 16.8) in those without (p<0.0001). No gender difference existed in 
patients with diverticulosis.  
Polyps were seen significantly more in men than in women [703 (55%) vs. 579 
(45%); p<0.0001]. No difference in distribution of ANL was found between 
men and women, 348 (53%) vs. 258 (39%), respectively (p=0.12). ANL were 
seen more often in the recto-sigmoid colon than the rest of the colon, 465 
(36%) vs. 386 (30%), p=0.002 (Table 1). Invasive adenocarcinoma and 
adenomas ≥10 mm were most frequently observed (Table 1).  
Though unstratified analysis seemed to show an association between 
patients with polyps and diverticulosis and those without diverticulosis [916 
(71 %) vs. 366 (29%)], however, age stratified analysis showed no relationship 
(p=0.478).  
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Table 1. Histopatholical results and location of the polyps  
A negative relation was observed between diverticulosis and CRC and 
invasive adenocarcinoma in age-stratified analysis (p<0.0001 and p=0.002, 
respectively). No association was found between polyps and CRC and 
patients with diverticulitis and CRC (Table 2). 
  Polyps (%) p value  OR CI 
Diverticulosis 916 (71) 0.478 0.94 0.8–1.1 
Diverticulitis 23 (1.8) 0.695 0.87 0.5–1.4 
CRC (%) 
Diverticulosis 88 (23.6) <0.0001 0.54 0.4–0.7 
Diverticulitis 3 (0.8) 0.116 0.36 1.1–1.2 
Polyps 133 (35.7) 0.824 0.03 0.2–0.3 
Invasive adenocarcinoma (%) 
Diverticulosis 175 (26.4) 0.002 0.66 0.5–0.8 
Diverticulitis 11 (1.6) 0.43 0.66 0.2–1.5 
 
Table 2.  Relationship between diverticulosis/diverticulitis with polyps, 
colorectal carcinoma (CRC), and invasive adenocarcinoma  
Advanced neoplastic lesions Localization 
of the polyps  
 
Adenomas 
≥10 mm   
N (%) 
Invasive 
adenoca. 
N (%) 
Villous 
adenoma 
N (%) 
High 
grade 
displasia 
N (%) 
Total 
N (%) 
Benign 
polyps   
N (%) 
Total    N 
(%) 
Rectum 59 (37) 154 (38) 30 (79) 19 (34) 262 (40) 153 (25) 415 (32) 
Sigmoid 48 (30) 131 (32) 2 (5) 22 (39) 203 (31) 233 (38) 436 (34) 
Colon 
descendens 10 (6) 30 (7.5) 0 1 (2) 41 (6) 61 (10) 102 (8) 
Transversum 9 (5) 17 (4) 1 (3) 1 (2) 28 (4) 46 (7) 74 (6) 
Colon 
ascendens 21 (13) 36 (9) 4 (10) 8 (14) 69 (10) 82 (13) 151 (12) 
Cecum 14 (9) 38 (9.5) 1 (3) 5 (9) 58 (9) 46 (7) 104 (8) 
Total 161       (24) 
406 
(61.5) 
38        
(6) 
56     
(8.5) 
661 
(51.5) 
621 
(48.5) 
1,282 
(100) 
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DISCUSSION 
In this retrospective, cross-sectional study, we examined the relationship 
between diverticulosis, diverticulitis, polyps, ANL, and CRC in a group of 
4,241 consecutive patients undergoing colonoscopy for various reasons.  
In our study, diverticulosis was reported in 25% of patients. Underreporting 
and selection bias may play a role. Diverticulitis was seen in 2% of the 
patients, which is less than the previously reported prevalence of 5% 22. This 
is probably due to the fact that, in many cases, computer tomography is 
performed when diverticulitis is suspected, rather than colonoscopy. Polyps 
were observed in 30% of the patients, of which half (51%) were ANL. The 
polyps and ANL were found predominantly in the recto-sigmoid colon. This 
finding is consistent with other studies, where the left colon is the principal 
site of ANL and polyps 23-25. 
CRC was present in 9% of the patients. This included patients with a 
previously resected CRC. Since the reason for colon resection was not 
always reported, underreporting also might play a role here.  
The prevalence of both diverticulosis and adenomas increases with 
advanced age 3-5,23,26 as was also shown in our results.  
We have not observed any gender domination in patients with 
diverticulosis, ANL, and CRC. However, polyps were seen more often in men 
than in women. The increasing prevalence of polyps in young male patients 
was already observed in a recently published study 24. 
We observed a negative correlation between diverticular disease and CRC 
as well as invasive adenocarcinoma. Furthermore, we did not find any 
association between polyps and CRC or diverticulitis and CRC. How can 
this discrepancy in the literature, including our results, be explained? Table 3 
summarizes the studies regarding this subject.  
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Author Year Diverticulosis Diverticulitis Polyp Carcinoma Note 
Stefanson 
et al. 17 1993 +   left side ↑ 
mixed 
diverticulosis 
and 
diverticulitis 
Loffeld et 
al. 1 2002 +   ↑ ↓ 
many polyp 
surveillance 
Morini et 
al. 15 2002 +   
sigmoid↑ 
ANL in 
sigmoid↑ 
=   
Kieff et 
al. 16 2004 +   
women ↑ 
distal and 
advanced 
  
no previous 
polypectomy or 
surgery 
+     = Stefanson 
et al. 21 2004   +   4.2 ↑ 
longitudinal, 
case control 
study 
Krones et 
al. 19 2006 + + ↓ ↓ 
only 18% 
diverticulosis in 
CRC 
Soran et 
al. 20 2006 +     
prognosis 
after colonca 
= 
10% diverticula 
in colonca after 
resection for 
colonca 
Choi et al. 
18 2007 +     
both left and 
right sided ↑
no previous 
polypectomy or 
surgery 
+   = ↓ Meurs-
Szojda 2008   + = = 
many polyp 
surveillance 
 
Table 3. Review of literature: relationship between diverticulosis, diverticulitis, 
polyps, and colon carcinoma.  
ANL Advanced neoplastic lesion, CRC colorectal cancer 
 
There are nine studies, including ours, concerning diverticulosis, polyps, and 
CRC 1,15-21. Three studies described an increased incidence of polyps in 
patients with diverticulosis 1,15,16. However, only one of these studies 
considered the confounding influence of age 15. We did not find any 
relation between patients with polyps and incidence of diverticulosis when 
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using age-stratified analysis. In the light of our results, it seems vital to make 
an age-stratified analysis. 
One study only included first time colonoscopies without prior polypectomy, 
colorectal surgery, or inflammatory bowel disease 16. Although the number 
of included patients was only 502, selection bias was minimal. Another  
study 19 found a lower incidence of polyps. Since these are retrospective 
studies, underreporting might be due to the fact that a substantial part of 
colonoscopies performed, consisted of follow-up colonoscopies after 
polypectomy or after partial colon resection.  
Eight studies, including our own, concern the relationship between 
diverticulosis and carcinoma 1,15,17-21. One recent study from Korea found an 
increased risk of CRC in both patients with left- or right-sided diverticulosis 
without prior polypectomy or surgery in the affected area 18. Three studies 
showed no relationship between diverticulosis and CRC, one of them being 
a longitudinal study 21. The two other studies showed no prognostic 
difference in patients with and without diverticulitis after removal of CRC 20 
and the same prevalence of CRC in both groups of patients 15. Two    
studies 1,19 besides ours found less CRC in patients with diverticular disease. 
Again, selection bias could play a role. 
There are two studies besides ours concerning the relationship between 
diverticulitis and CRC 19,21 and one regarding polyps 19. Stefanson describes 
a longitudinal, case control study in 7,159 patients with a prior diverticulitis 
and a follow up of at least 20 years in which he finds an increased risk 
(OR=4.2) for left-sided CRC 21. Krones et al. 19  looked retrospective at 
resected specimen for CRC for diverticulitis and in resected diverticulitis for 
ANP. In the CRC group, the incidence of diverticulosis was only 18% and 
ANP in the diverticulitis group only 6%, both very low numbers 23-25. 
Subsequently, a negative relationship was found. Our study showed no  
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difference and also suffers from confounding factors like underreporting 
and previously removed polyps and CRC.   
Although only one study 21 has demonstrated the relationship between prior 
diverticulitis and development of CRC, the sequence seems logic. Many 
patients with diverticulitis will experience recurrent attacks, and chronic 
inflammation can lead to overt carcinoma as is well known in patients with 
inflammatory bowel disease 27,28 and Helicobacter pylori 29.  
This concept is supported by studies in vitro, although contradictory results 
are also found in this study. One study showed an elevated C-reactive 
protein concentration in blood of the persons who developed colonic 
cancer after several years 30. One of the possible explanations for the 
association between diverticular disease and colorectal cancer is that the 
presence of an inflammation process increases the risk for a malignant 
transformation 30 since, in the western population, both diseases occur 
usually in the left colon. A study in patients with diverticular disease 
demonstrated that hyperproliferation of the colonic mucosa was localized 
in the upper third of the colonic crypts 31. Hyperproliferation of the colonic 
mucosa was detectable in the whole length of the colonic crypts in the 
patients not only with symptomatic diverticulosis and acute diverticulitis but 
also in patients with asymptomatic diverticulosis 32. This suggests that not 
only patients with acute diverticulitis but also those with asymptomatic 
diverticulosis are at a risk of developing adenomas and CRC. Recently, an 
abnormal expression of M1/MUC5AC mucin [found in (pre)cancerous 
lesions] in the distal colon of 26% of patients with diverticulitis was found 33. In 
contrast, a different matrix microenvironment was found between the 
colonic tissue architecture of the patients with colon cancer and those with 
diverticular disease, thus implying no predisposition for cancer in diverticular 
disease 34.  
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Now, what should we believe? Clearly, a longitudinal study following 
cohorts of patients with diverticulosis or diverticulitis is the best. However, 
some firm conclusions can be drawn. Considering the fact that more than 
60% of patients above the age of 60 will have diverticula, it is obvious that 
screening from this point of view is useless, even if there were a very slight 
increased risk.  
How about diverticulitis? This is more complicated. In our group, there were 
not so many patients with diverticulitis (75) compared to the group of 
Stefanson et al. 21 (7,159), which were also followed as a cohort and found 
a positive relationship. But the surgical resection specimens of Krones et     
al. 19 were thoroughly examined, and he found less polyps and cancer. The 
difference could lie in the moment of endoscopy or surgery. Some find 
surgery mandatory after a first recurrence while others follow a more 
liberated policy 35. Furthermore, additional or more adequate treatment 
may alter the disease and lead to less recurrences 36, thus reducing the 
chance for chronic inflammation. It seems that the common practice to 
perform a colonoscopy after a cured diverticulitis to rule out a malignancy 
is valuable. If any polyps are found, surveillance can occur as usual. 
Probably, the patient with continuous inflammation or frequent attacks of 
diverticulitis merit more attention.  
Increasing diverticular disease and therefore diverticulitis around the world 
poses interesting questions regarding the long-time consequences for these 
patients and possible colonoscopy screening. This certainly merits more 
attention and research. Further longitudinal studies and awareness of 
underreporting are necessary, which can be overcome by standardized 
endoscopy reports.  
In conclusion, no relationship between diverticular disease and colon 
neoplastic disease was found. Although some critical points can be made 
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about the study design, some conclusion can be drawn from this study and 
the existing literature. Diverticulosis probably bears no relationship with 
colonic neoplastic lesions. Maybe, some patients with chronic or recurrent 
diverticulitis are at risk. The general clinical practice that patient should 
have a colonoscopy after a cured diverticulitis to rule out a carcinoma 
holds true. Those with polyps should enter a surveillance program. Probably, 
the patient with recurrent attacks of diverticulitis merit more attention.  
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Abstract 
Objective 
This study was designed to assess the relationship between diverticulitis and 
the development of colorectal carcinoma (CRC) and colonic adenomas. 
Materials and methods  
A retrospective study was longitudinally conducted. Patients who had been 
admitted to the hospital between 1990-2000 with diverticulitis were retrieved 
and the incidence of CRC and prevalence of colonic adenomas in these 
patients were determined. Data were collected from the electronic clinical 
and pathology records. The incidence of CRC and prevalence of 
adenomas in this patient cohort was compared with the general 
population. The patients were followed up till 2008. 
Results  
A total of 288 patients with diverticulitis were included (167 females [58%]). 
The mean age of patients at admittance for diverticulitis was 66 year (range 
27-92). CRC was detected in 5 patients (1.7%) (95% CI 0.8-3.5), at a mean 
age of 77 year; colonic adenomas were found in 18 patients (6.3%) (95% CI 
4.3-9.0), at a mean age of 62 year. The lifetime risk of developing CRC and 
adenomas were presumed to be 4% and 20% respectively. Calculated 
expected rates in our patients for CRC and adenomas were 17 (95% CI 4.0-
8.6) and 69 patients (95% CI 20.1-28.3) respectively. 
Conclusion  
This study showed a lower prevalence of CRC and colonic adenomas in 
patients with diverticulitis compared to the lifetime risk, which means that 
diverticulitis is not a risk factor for development of CRC and adenomas. 
Long term colonic screening after a negative colonoscopy for diverticulitis 
generally performed several weeks after recovery, seems not to be justified. 
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INTRODUCTION 
The relationship of diverticular disease and colorectal cancer (CRC) 
remains unclear. A possible association between diverticulosis and CRC has 
been reported by several investigators 1-4. In contrast, some authors failed to 
show any association 5 or described a decreased risk for CRC 6. 
Studies have shown similar epidemiological features for both diseases. A 
recent report by the American Gastroenterological Association (AGA) on 
the burden of digestive illnesses indicates that diverticular disease 
represents one of the five most important gastrointestinal diseases in the 
Unites States and the prevalence has increased since the last century 7,8. 
CRC, one of the most common malignancies in the world, has shown a 
similar trend. Furthermore both diseases are more frequent in developed 
countries and are age-dependent, as both are uncommon in those under 
the age of 40 9,10. It has been estimated that the lifetime risk of developing 
CRC and colonic adenomas is 2.5-6% and 10-20% respectively 11-14. In 
addition, both diseases share a similar distribution. Although a gradual shift 
toward right-sided colonic leasion has been observed, most of them are 
mainly left sided 14,15. Diverticulitis develops commonly in the left colon as 
well, especially in the sigmoid 16. 
A possible explanation for the association between the two diseases is that 
they share similar risk factors. They have the same pathogenic factors, such 
as the Western diet, low in dietary fiber and rich in saturated fat 17. A causal 
relationship between the two diseases has also been suggested 3. In the 
literature several macroscopic and microscopic alterations of diverticular 
disease are described 18. One of the most important is the chronic 
inflammation, because chronic inflammation is a risk factor for cancer. The 
link between chronic inflammation and cancer is well documented in 
patients with ulcerative colitis, gastritis, esophagitis and hepatitis 19-21.  
A recurrent or chronic inflammation of the colon occurs in a number of 
patients with diverticulosis 18. Moreover, 0.8 % of patients with diverticulosis 
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without any symptoms had sign of diverticular inflammation on the 
endoscopy 22. 
In theory, it could be speculated that patients with diverticulitis have a 
higher risk of developing CRC than patient with a few outpouchings of the 
mucosa through the muscular layers. 
The aim of the present cohort study was to evaluate a possible association 
between diverticulitis and CRC.  
Materials and methods 
Patients who had been admitted to the VU University Medical Center 
between 1990 to 2000 with diverticulitis were retrieved from the hospital 
database to determine the possible incidence of CRC and the prevalence 
colonic adenomas in these groups. The diagnosis diverticulitis was 
confirmed with CT-scan and / or surgery.  
The descriptive characteristics of the study cohort were analyzed with 
respect to age, gender, any history of diverticulitis, preceding presence of 
malignancies and co-morbidities.  
All patients who received a conservative treatment during their admission, 
were followed up by evaluating the Hospital Electronic Medical Record and 
the pathology reports, which are stored in the PALGA system. This system is a 
nationwide network and registry of histo- and cytopathology in the 
Netherlands.  
Of all patients who underwent surgery for diverticulitis, the Hospital 
Electronic Medical Record and the pathology report of the resected 
specimen was reviewed. These patients were not followed up, because the 
colonic resection removed the affected post-diverticulitis colon, which 
excluded  the development of cancer in that part.  
The time of observation of patients with a conservative treatment was 
calculated from the date of the first admission episode with diverticulitis of 
the colon until death or the end of the observation period.  
The Medical Ethical Commission of the VU University Medical Center 
granted permission. 
                                                                                                                                              
  115  
Statistical analysis 
The lifetime risk for CRC and adenomas in this patient cohort were 
compared to the general population with representative data from the 
literature. Studies described a lifetime risk variation of 2.5-6% for CRC and 10-
20% for colonic adenomas 11-14. To reduce any underreporting, the 
expected rates were calculated with a lifetime risk of 4% for CRC and 20% 
for colonic adenomas. A confidence interval was used to define the 
lifetime risk. Analyses were performed with the statistical software SPSS 16.0. 
RESULTS 
Between 1990 and 2000, a total of 288 patients with diverticulitis were 
admitted to the hospital (167 [58%] female). The mean age of the patients 
diagnosed with diverticulitis at admission was 66 years with a range of 27-92 
years. The mean age at the end of the observation time was 71 years with 
range of 28-100 years. In total 76 patients died. Besides CRC, 39 patients 
(13.5%) patients were diagnosed with other malignancies (Table 1). 
 
 
 
Total  
patients 
n = 288  
Patients with 
conservative 
treatment 
n=106 
Colorectal 
cancer 
n = 5  
Colonic 
adenomas 
n =18  
Mean age  
years (range) 
 
66 (27-92) 
 
68 (29-92) 
 
77 (66-86) 
 
62 (38-81) 
Gender  
Male    n (%) 
Female n (%) 
 
121 (42.0) 
167 (58.0) 
 
47 (44.3) 
59 (55.7) 
 
0 
5 (100) 
 
10 (55.6) 
8 (44.4) 
Recurrence of 
diverticulitis n (%) 
     100 (34.7)     26 (24.5)      1 (20.0)      5 (27.8) 
Presence of (other) 
malignancies n (%) 
39 (13.5) 
- Breast 
      - Skin 
    - Prostate 
15 (14.2) 
- Breast 
     - Skin 
    - Prostate 
3 (60.0) 
- Breast 
2 (11.1) 
- Breast 
 
Table 1. Characteristics of patients 
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A total of 182 (63.2%) patients (of these, 53 patients first received a 
conservative treatment) underwent an operation as a result of diverticulitis, 
whereas the remaining 106 (36.8%) patients received a conservative 
treatment.  
Of the 106 patients with conservative treatment, no further pathology 
reports existed for 12 (11,3%) patients. The follow-up ranged from 0 to 18 
years, with a mean follow-up of 12 years. One patient died a few weeks 
after the conservative treatment. During the follow-up 26 (24,5%) patients in 
this group had a recurrent episode of diverticulitis. 
CRC was detected in 5 (1.7%) patients at a mean age of 77 years, all 
female (Table 1). As shown in table 2 the 95% confidence interval was 0.8-
3.5. The calculated expected rate for CRC was 17 (95% CI 4.0-8.6) patients 
(Table 2). After subclassification according to treatment, the 95% CI of 
patients with a conservative treatment was 0.6-5.5 and the calcuated 
expected rate was 8 (95% CI 4.3-12.9) patients. 
In 3 (60%) cases CRC was diagnosed during the first recorded episode of 
diverticulitis. These patients underwent a sigmoid resection. In two cases CRC 
was diagnosed 4 and 15 years after their first admittance respectively. Three 
(60%) patients had breast cancer as co-morbidity.  
Colonic adenomas were identified in 18 (6.3%) patients, at a mean age of 
62 year, with 8 (44.4%) female (Table 1). The 95% confidence interval was 
4.3-9.0. The calculated expected rate for adenomas was 69 (95% CI 20.1-
28.3) patients (Table 2).  
In 8 (44.4%) cases colonic adenomas was diagnosed during the first 
recorded episode of diverticulitis. In the remaining 10 cases colonic 
adenomas was diagnosed after 1 to 12 years with a mean of 3.4 years. Two 
(11.1%) patients with colonic adenomas had breast cancer as co-morbidity.  
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CRC Number 
patients 
(%) 
95% Confidence 
interval 
Expected 
number  
patients (%) 
95% Confidence 
interval 
 
Total patients 
(n=288) 
Conservative 
treatment (n=106) 
Surgical treatment 
(n=182) 
 
5 (1.7) 
 
2 (1.8) 
 
3 (1.6) 
 
0.8-3.5 
 
0.6-5.5 
 
0.7-4.0 
 
17 (5.9) 
 
8 (7.5) 
 
12 (6.6) 
 
4.0-8.6 
 
4.3-12.9 
 
4.2-10.3 
Colonic adenomas     
 
Total patients 
(n=288) 
Conservative 
treatment (n=106) 
 
18 (6.3) 
 
11 (10.4) 
 
4.3-9.0 
 
6.5-16.3 
 
69 (23.9) 
 
28 (26.4) 
 
20.1-28.3 
 
20.0-34.0 
 
Table 2. 95% Confidence interval of patients with CRC and colonic 
adenomas 
 
DISCUSSION 
This retrospective longitudinal study which included 288 patients, found no 
association between patients with diverticulitis and CRC and patients with 
diverticulitis and colonic adenomas.  
This absence of an association between diverticulitis and CRC correlates 
with the results of two other studies. In our previous cross-sectional, 
retrospective study we observed a negative correlation between 
diverticulitis and CRC as well as with polyps in 4241 colonoscopies 23. CRC 
and invasive adenocarcinoma were detected in 3 patients (4%) and 11 
patients (14.7%) respectively. The retrospective study by Krones et al. 
involving 512 patients showed that diverticulitis was no risk factor for 
advanced colonic neoplasia 6.  
However, this contrasts with the finding of Stefansson et al. 24. The authors 
reported in a retrospective case control population based cohort study 
                                                                                                                                              
  118  
involving 7159 hospitalized patients with diverticulosis and diverticulitis that 
there is an increased risk for a long-term left-sided CRC in diverticulitis 
patients.  
 
Thus, in total 4 studies, including the present study, documented diverticulitis 
and CRC / colonic adenomas and are controversial (Table 3). Three 
showed no association and the remaining study, which included a large 
number of patients, found a positive relationship. The controversial findings 
may reflect the influence of surgical therapy as suggested in our previous 
study. Adequate treatment may lead to less recurrences and a reduced risk 
for CRC. The patients of Krones et al. all underwent a colonic resection for 
diverticulitis, which might reduce the risk of developing CRC 6. In the study 
of Stefansson et al. no information was given about the frequency of 
surgical treatment 24.  
It has been speculated that diverticular disease may correlate with a high 
epithelial cell proliferation. Morini et al. demonstreted hyperproliferation in 
the upper third of the colonic crypts of the sigmoid mucosa in patients with 
diverticular disease 25. This finding has been confirmed by Tursi et al. 26. They 
ditected an upward shifting of cellular proliferation in the whole length of 
the colonic crypts in the patients with symptomatic diverticulosis and acute 
diverticulitis. In addition, hyperproliferation was also ditected in 
asymptomatic patients with diverticulosis which implies that those may be 
at risk for developing CRC as well. In contrast, a recent study regarding the 
microenvironment did not support this concept. Klinge et al. showed group-
specific differences the the colonic tissue architecture of the patients with 
CRC and patients with diverticulitis 27. This suggests that there may no 
predisposition for cancer in diverticular disease and may explain the low 
rate of CRC in diverticulitis patients. However, the complex crosstalk within 
the cellular and extracellular matrix remains uncomplited. Further 
investigation is needed. 
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Author Stefansson 24 Krones 6 Meurs-Szojda 23 Lam 
Year 2004 2006 2008 2009 
Study case control 
cohort 
 
retrospective retrospective 
cross-sectional 
retrospective 
cohort 
Patients with 
diverticulitis  
n 
7159 patients 
with 
diverticulose 
and 
diverticulitis 
 
512 75 288 
diverticulitis 
patients with 
colonic 
neoplastic 
lesion  n (%) 
46 diverticulitis 
patients with 
CRC 
 
in total 64 
cases with 
cancer and 
123 controls 
 
28 (6) 
advanced 
colonic 
neoplastic 
lesion 
3 (4) CRC 
 
11 (14.7) invasive 
adenocarcinoma 
5 (1.7) CRC 
 
18 (6.3) 
adenomas 
mean follow 
up years 
(range) 
 
no information 
(±6 - ±26) 
9 (3-17) not applicable 12 (0-18) 
therapy 
n (%) 
 
no information all resection not applicable 182 (63.2) 
resection 
conclusion increased risk reduced risk no increased risk no increased risk 
 
Table 3. Review of studies concerning association between diverticulitis and 
colonic neoplastic lesions. 
 
Moreover, studies concerning the association between diverticular disease 
and CRC are also controversial. In the literature, nine studies were reported 
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regarding this subject. One study demonstrated an increased incidence of 
CRC  in patients with diverticulosis 3, two studies showed no difference in 
CRC 24,28 and  three studies found a decreased incidence 5,6,23. Regarding 
the polyps, three studies showed an increase of prevalence 2,4,5, one study 
no difference 23 and one study a decrease 6. 
Surprisingly, in this study the diverticulitis patients who developed CRC were 
all female. Gender has not been established as a risk factor for CRC. 
However, in the literature the incidence of CRC is even slightly higher in 
men. Nevertheless, the incidence rates for cancer have increased 
particularly in women, because of the increased carcinogenic habit of 
smoking cigarettes 29. Unfortunately, smoking habit was not recorded in the 
present study. 
Nonetheless, there are some limitations in our study that should be 
considered when interpreting these findings. The first limitation is the 
observation time. Although the present results may be due to a short follow 
up compared with the study if Stefansson et al. 24, the study population has 
reached a mean age of 66 years at first admission. Since incidence rates 
increase sharply after the age of 50 years 30, it could be considered that our 
mean age finding would not lead to an underestimation of CRC. 
Furthermore, a previous episode of diverticulitis was only recorded if the 
patients were investigated at our hospital. Regarding the lack of 
information bias in the collection the first episode of diverticulitis, the 
approach of calculating the duration of diverticulitis and developing CRC, 
may underestimate the actual transition duration.  
Secondly, the included patients are a hospital-based population. Patients 
with diverticulitis without admission to the hospital were not included, which 
may cause an underriporting of diverticulitis. A sublinical diverticulitis 
inflammation could be presented 22. However, in theory, patients who were 
admitted, have a more significant illness episode of diverticulitis than those 
who were not. A more severe diverticulitis usually requires surgical 
intervention, which can cause a bias. Both diseases are mainly located in 
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the left colon 14-16. Therefore, colonic resection due to diverticulitis could 
eliminate the chance of developing CRC, which means that the 
association between severe diverticulitis and CRC has not been ruled out. 
Thirdly, there could be an underreporting of the prevalence rate of 
neoplasia and polyps. This seems especially the case with polyps, since they 
rarely give complaints. Small sized CRC usually only cause mild complaints, 
which might lead to underreporting as well, but larger CRC will generally 
give clinical symptoms and even in the very old or debilitated patients the 
diagnosis would have been established. 
 Fourthly, as table 1 showed, 3 patients with CRC (60%) had breast cancer 
as co-morbidity. Therefore, CRC may be caused by inherited genetic 
predispositions which leads to breast cancer and not by diverticulitis. Brose 
et al. showed an increased risk of cancer of the colon in patients with 
breast cancer 31. 
 The last limitation is that a preceding simultaneous presence of two 
diseases was not ruled out. CRC can develop simultaneous in diverticulitis 
patients. However, the incidence of CRC was still low in diverticulitis patients 
and did not meet the calculated expected rates for CRC. 
In conclusion, the present study found no association between diverticulitis 
and CRC, and diverticulitis and colonic adenomas. Therefore, there is no 
need to justify any screening procedures for early detection of cancer in 
patients with a history of diverticulitis. However, this should be interpreted 
with caution. Regarding the fact that in 3 of the 5 patients CRC was 
detected during the first episode of diverticulitis, it is maybe worthwhile to 
perform a colonoscopy to rule out any concomitant presence of CRC after 
a cured diverticulitis as is the current strategy. 
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Abstract 
Objective 
It is suggested that bowel preparations for colonoscopy are easier to 
tolerate when a smaller volume of solution with a more pleasant taste is 
used. The aim of this study was to establish equivalence between a 3-l 
sulphate-free polyethylene glycol solution (SF-PEG) and a 4-l PEG solution in 
effectiveness, patients' acceptability and tolerability.  
Material and methods  
The study comprised 110 patients scheduled for elective colonoscopy and 
randomized to receive either SF-PEG or PEG. Before colonoscopy, the 
patients completed a questionnaire on stool frequency, medication, 
concomitant diseases, the amount of solution ingested, willingness to retake 
it, volume of other fluid taken and tolerance of bowel preparation, taste of 
the laxative and occurrence of abdominal cramps. Three experienced 
endoscopists, blinded to the type of preparation, assigned bowel-cleansing 
scores using a validated 5-point scale to assess cleansing effect.  
Results  
Data were available for 102 patients (44 male (40%), mean age 53 years, 
range 23-83 years). No significant differences were found in cleansing the 
rectosigmoid (p=0.71) or complete colon (p=0.79). Diverticulosis, 
constipation, gender and body mass index (BMI) did not influence 
cleansing. There was no significant difference in compliance between the 
two groups (p=0.61). No differences were found for tolerance, taste and 
abdominal cramps. Patients who received SF-PEG had a preference for the 
same preparation next time in comparison with patients who had PEG 
cleansing (17 (33%) versus 4 (8%), respectively) (p=0.03).  
Conclusions  
Both preparations are comparable in their cleansing effect and toleration. 
However, patients prefer cleansing with a smaller volume of solution. 
Improving the acceptability of colonic preparation could improve 
willingness to undergo colonoscopies in the future.  
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INTRODUCTION 
Colonoscopy is an essential procedure for the detection and treatment of 
colonic lesions. Therefore, cleansing the bowel for adequate visualization of 
the colonic mucosa during the procedure is important. Elective 
colonoscopy is of major importance in screening and surveillance programs 
for patients with colorectal cancer, which is a leading cause of cancer 
mortality in the Western world 1,2. Inadequate preparation can result in 
missed polyps and other lesions 3-6 and can prolong the insertion time, as 
well as increasing the risk of complications and patient discomfort 7,8. 
Colonic cleansing is generally done with solutions containing high 
molecular-weight polyethylene glycol (PEG), sodium phosphate, 
magnesium citrate, or bisacodyl 9-13. PEG solutions are considered to be the 
gold standard for bowel cleansing in many countries and their efficacy and 
safety have been well established in more than 50 controlled trials. 
However, many of these solutions require intake of large volumes of fluid, 
which is disadvantageous to their use and reduces acceptability in  
patients 11. Some studies comparing different regimens and solutions in 
precolonoscopy bowel cleansing suggest that regimens with larger 
amounts of colonic fluid are poorly tolerated by patients 6,14-21. Patients are 
often unable to ingest sufficient quantities of the solution, which leads to 
inadequate colon cleansing, amounting to 10-75% in randomized 
controlled trials 7,13,18,22. Poor bowel preparation has been associated with 
patients' characteristics such as a history of constipation, use of 
antidepressants and non-compliance with cleansing instructions 8,23,24. Safe 
and effective colonic cleansing is crucial for a correct diagnosis, which 
often decides on efficient treatment without unnecessary delay. The 
importance of patient acceptability is often underestimated and is not 
seriously considered, despite it being responsible for poor compliance with 
the cleansing regimen. In this study we compared the effectiveness, patient 
acceptability and physical tolerability of a sulphate-free (SF) 3-l PEG solution 
(SF-PEG) versus 4-l PEG solution for bowel preparation prior to colonoscopy. 
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Material and methods  
From November 2006 to February 2007, 110 patients scheduled for elective 
colonoscopy in our outpatient clinic were enrolled in this study. Eligible 
patients who had given informed consent were prospectively randomized 
to receive either 3-l SF-PEG, or 4-l PEG. The two bowel-preparation 
schedules were also randomized. Exclusion criteria included gastrointestinal 
obstruction, bowel perforation, obstructive or paralytic ileus, pregnancy, 
immobility of the patient, unstable angina or other disease that might 
interfere with the study. Patients who were not able to consume enough of 
the preparations safely to initiate colonoscopy were also excluded from the 
study. 
Demographic characteristics such as age, gender, weight, height, stool 
frequency per week, previous bowel preparation, bowel surgery and 
additional medical history were obtained for all patients. Both preparations 
were administered in compliance with the prescription information. For a 
morning procedure, patients started with ingestion of 3-l SF-PEG or 4-l PEG 
the evening before the procedure. For an afternoon procedure, patients 
began ingestion of the prescribed solutions the morning of the day of the 
procedure. During and after lavage, patients were restricted to a fluid-only 
diet. 
On the day of presentation for colonoscopy, patients were requested to 
complete a detailed questionnaire. The questions concerned the amount 
of PEG preparation the patient actually ingested, time between fluid intake 
and colonoscopy, volume of other fluid taken before colonoscopy, taste of 
the preparation (1=very unpleasant taste and 4=very good taste), 
tolerance of bowel cleansing (1=very bad, 4=very good), abdominal 
cramps (1=severe, 4=none) and the willingness of the patients to retake one 
of the solutions in the future. Three experienced endoscopists, blinded to 
the type and quantity of the preparations, assigned a bowel-cleansing 
score using the Aronchick 5-point scale 25 to assess bowel cleansing in each 
segment of the colon and for overall examination. For clinical purposes, we 
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mention only bowel cleansing in the rectosigmoid and overall colon since, 
in our clinical experience, the rectosigmoid is often not clean while the rest 
of the colon is. Diverticula, polyps or other endoscopic lesions found during 
the procedure were noted. 
The caecum was detected and defined endoscopically. The study protocol 
was approved by the VU University Medical Centre Ethics Commission. 
Statistical analysis  
To decide on the size of the study sample, we carried out a power analysis 
beforehand. Assuming a standard deviation of 1.0 for the Aronchick scale, 
we needed an overall sample of 99 patients, in order to show an 
equivalence between the two groups defined by a difference in mean 
Aronchick scale of less than 0.5 (=0.05, β=0.8). To guard against a 10% 
dropout, we included 110 patients in the study. Medians were calculated 
and compared where appropriate with the Mann-Whitney test; χ2 tests and 
trend tests were used to compare percentages (GraphPad InStat Software, 
San Diego, Calif., USA). 
 
RESULTS 
Data were available for 102 patients (44 (40%) male, 66 (60%) female, mean 
age 53 years, range 23-83 years). Eight of the patients were excluded 
because of failed bowel preparation (3 in the 3-l SF-PEG group and 5 in the 
4-l PEG group). There were no differences in demographic findings between 
the two study groups (Table 1).  
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 3-l SF-PEG 4-l PEG  
Demographic characteristics n=51 (%) n=51 (%) p-value 
Age, mean±SD (range) 52±13.7 (24-83) 53±12.6 (23-81) 0.605 
Gender    
Male 18 (17.6) 22 (21.6) 0.490 
Female 33 (32.4) 29 (28.4)  
BMI    
Small (BMI <21) 6 (5.9) 3 (2.9) 0.270 
Medium (BMI: 21-24) 15 (14.7) 20 (19.6)  
Large (BMI >24) 30 (29.4) 28 (27.5)  
Sigmoid resection 2 (4) 3 (6) 0.812 
Hysterectomy 1 (1) 4 (3.9) 0.362 
Diabetes on medication 6 (5.8) 4 (3.9) 0.740 
Regular laxatives 2 (1.9) 4(3.9) 0.677 
Earlier colonoscopy 28 (55) 26 (51) 0.723 
Bowel movements per week    
≤3 4 (3.9) 0 0.516 
4-7 33 (32.3) 34 (33.3)  
8-14 7 (6.9) 11 (10.8)  
>14 7 (6.9) 6 (5.9)  
Findings at colonoscopy    
Polyps 7 (6.8) 9 (8.8) 0.786 
Diverticular disease 15 (14.7) 24 (23.5) 0.102 
Colorectal cancer 0 4 (3.9) 0.117 
Inflammatory bowel disease 5 (4.9) 3 (2.9) 0.715 
Haemorrhoids 5(4.9) 4 (3.9) 1.00 
Table 1. Demographic characteristics.   
PEG=polyethylene glycol; BMI=body mass index; SD=standard deviation. 
Assessment of bowel cleansing  
The caecum was reached in 91 patients (90%). Six times in the 3-l SF-PEG 
group and 5 times in the 4-l PEG group the caecum was not reached. 
We showed equivalence between the two preparations (Table 2). The 
endoscopists scored the effect of the colonic lavage of the rectosigmoid 
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with the 3-l SF-PEG and 4-l PEG solutions as “excellent” or “good” in 40 
patients (78%) versus 35 patients (69%), respectively (p=0.71). For cleansing 
of the complete colon this was 34 (68%) and 33 (69%) patients, respectively 
(p=0.79).  
The computed confidence intervals for the Aronchick scale were -0.340, 
0.498 and -0.485, 0.372 for the rectosigmoid and overall colon, respectively. 
Neither of the intervals contained +0.5, so equivalence of the 3-l SF-PEG 
solution and 4-l PEG solution has been shown.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Quality of bowel-cleansing preparation in patients. One overall 
colon result is missing in the 3-l PEG group and three results in the 4-l PEG 
group. 
SF=sulphate-free; PEG=polyethylene glycol. 
 
There was no difference in effectiveness of the bowel preparation between 
colonoscopies performed in the morning or in the afternoon and between 
the 3-l SF-PEG and 4-l PEG groups, although there was a small tendency 
towards overall colonoscopy, which failed to reach statistical significance 
(morning “excellent” or “good” in 50 out of 67 patients (75%) versus 
 3-l SF-PEG 4-l PEG 
Quality of cleansing n=51 (%) n=51 (%) 
Rectosigmoid p=0.71 
Excellent 22 (43) 19 (37) 
Good 18 (35) 16 (31) 
Adequate 6 (12) 13 (26) 
Poor 2 (4) 2 (4) 
Inadequate 3 (6) 1 (2) 
Overall colon p=0.79 
Excellent 17 (34) 16 (33) 
Good 17 (34) 17 (36) 
Adequate 11 (22) 11 (23) 
Poor 2 (4) 3 (6) 
Inadequate 3 (6) 1 (2) 
                                                                                                                                              
  132  
afternoon 19 out of 33 (57.5%) patients, p=0.10). Diverticulosis was 
diagnosed in 39 patients (38%); no difference in the cleansing effect of the 
rectosigmoid (p=0.26) and complete colon (p=0.22) was found overall and 
in the 3-l and 4-l PEG groups. The demographic and other endoscopic 
findings did not influence the cleansing results. 
 
Patients' acceptability and preference  
There was no significant difference in patient compliance between the 
group that ingested a 3-l SF-PEG solution and the group that ingested a 4-l 
PEG solution: 41 (82%) and 38 (76%), respectively (p=0.61) (Table 3). Mean 
time from the last preparation intake to colonoscopy was shorter in the 
group prepared with 3-l SF-PEG: 10.6 h versus 15.5 h (p <0.0001), and the 
mean volume of other fluids consumed before colonoscopy was smaller: 
475 ml versus 850 ml (p=0.0002). No significant difference was found in taste, 
which was assessed as “very good” 4 (3.9%) versus 2 (1.9%) times and “not 
good, but tolerable” 19 (18.6%) versus 15 (14.7%) times in the groups 
prepared with 3-l SF-PEG and 4-l PEG, respectively (p=0.11). Both groups of 
patients found that the bowel preparation was easy to tolerate, no 
differences in frequency or intensity of the abdominal cramps being 
detected between the two PEG solutions (p=0.62). No abdominal cramps 
were reported in 29 (28.4%) versus 32 (31.3%) patients and mild cramps in 17 
(16.6%) versus 14 (13.7%) patients prepared with 3-l and 4-l PEG, 
respectively.  
 
 3-l SF-PEG 4-l PEG p-value 
Amount of ingested PEG (%) 100 100 0.6097 
Volume of other fluids consumed before 
colonoscopy (ml) 300 1000 0.0002 
Time between bowel preparation and colonoscopy 
(h) 12 17 0.0000 
 
Table 3. Medians of bowel preparation parameters. 
SF=sulphate-free; PEG=polyethylene glycol; h=hours. 
                                                                                                                                              
  133  
Patients who received a 3-l SF-PEG lavage preferred the same preparation 
for future colonoscopy as compared with those who received a 4-l PEG 
lavage; 17 (33%) and 4 (8%), respectively (p=0.03). 
 
DISCUSSION  
Adequate bowel preparation for colonoscopy is essential and has  
a considerable impact on the quality of colon cleansing and diagnostic 
yield of colonoscopy. In this study we sought to determine whether a small 
volume of SF solution provides better efficacy and better toleration than a 
large volume of PEG solution, as was suggested in some studies 18,22,26.  
No difference was found in the quality of the bowel preparation between 
patients who received a 3-l SF-PEG or 4-l PEG solution. Our findings are 
consistent with the results of another study, which demonstrated equally 
good effectiveness and toleration of these two preparations 27. Those results 
are in contrast to the findings of another study, which demonstrated 
superior cleansing with a solution of 4-l PEG compared with 3-l SF-PEG for 
elective colonoscopy 10. However, these investigators used a divided two-
step preparation in accordance with the schedule of colonoscopies: a half 
dose in the afternoon on the day before the examination and the other half 
in the morning before the colonoscopy. The timing of the bowel 
preparation is suggested to play a role in the effectiveness of bowel 
cleansing prior to colonoscopy. In some studies it was found that the quality 
of cleansing was significantly better when preparation was done on the 
same day as the colonoscopy rather than when the whole preparation was 
carried out the day before the examination 6,23,28. In another study an 
identical regimen was used for bowel preparation the evening before, 
irrespective of the timing of the colonoscopy, and no difference in bowel 
cleansing was found 29. Although we adapted the bowel preparation 
according to the time of the procedure, we did not find any difference in 
efficacy of the bowel preparation between morning and afternoon 
sessions. 
                                                                                                                                              
  134  
Despite consumption of more additional fluids before colonoscopy and 
more time being given between completion of bowel preparation and 
colonoscopy (allowing more fluid loss) in the 4-l PEG group, no significant 
difference was found in the quality of colon cleansing between the two 
groups. 
In one study it was suggested that older age, female gender, a body mass 
index (BMI) ≤25, diverticular disease and constipation correlated with a 
difficult colonoscopy 30. Although the clinical experience is that in patients 
with diverticula characteristic faecal material can sometimes be seen, we 
could not demonstrate any difference in cleansing between patients with 
or without diverticula, as was shown in a previous study 15. 
Patients with constipation have a longer colon transit time than healthy 
volunteers 24 and could therefore have a less clean colon. We did not find a 
relationship between defecation frequency and a clean colon. 
In this study we found no difference in compliance between entire bowel-
cleansing preparation in patients prepared with 3-l SF-PEG and 4-l PEG 
solutions. 
However, patients preferred the 3-l SF-PEG cleansing, with 33% of patients 
saying they would be willing to use the same preparation again, compared 
with only 8% in the 4-l PEG group. This has already been suggested 
elsewhere 31.  
Our results showed no significant differences in taste, abdominal cramps 
and overall tolerance between the two PEG solutions. This is in agreement 
with an earlier study, which did not find any statistical difference in the 
overall acceptability, taste and cramping between the two solutions 32. 
In summary, both preparations proved to be comparable in their cleansing 
effectiveness and are well tolerated by patients. However, patients prefer a 
preparation with a smaller volume of solution. Improving the acceptability 
of colonic preparation could improve patients' compliance and the quality 
of the colonoscopy. 
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Abstract 
Background and aims 
Polyethylene glycol preparations (PEG) are increasingly used for chronic 
constipation in both adults and children. There are some suggestions that 
PEG 4000 with orange flavour (Forlax®) tastes better than PEG 3350 which 
contains salt (Movicolon®). Poor taste is an important factor for non-
compliance and is one of the leading causes of therapy failure. The aim of 
the study was to compare the taste of two commonly used polyethylene 
glycol preparations, PEG 4000 and PEG 3350 
Methods 
A double-blind, cross over randomised trial. Hundred persons were recruited 
by advertisement. All tasted both preparations without swallowing. After 
tasting each of the preparations, the mouth was rinsed. Then a score on a 
5-point scale was given for both preparations.  
Results 
100 volunteers were included (27 males and 73 females, mean age 36). The 
taste score for PEG 4000 (mean 3.9, SD 0.7) was significantly better than for 
PEG 3350 (mean 2.7, SD 0.7) (p<0.0001, Wilcoxon matched pairs test). No 
difference in gender or age was observed. The volunteers which tasted PEG 
3350 first appreciated it more than when tasted second (p<0.0001). The 
order in which volunteers tested PEG 4000 had no influence on the taste 
results.  
Conclusion 
PEG 4000 tastes better than PEG 3350. This may have implications for patient 
compliance and effectiveness of treatment in patients with chronic 
constipation. 
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INTRODUCTION 
Constipation is one of the most common health problems, with a negative 
impact on quality of life. The frequency of constipation is not exactly known, 
it varies from 2-4% for infrequent defecation to more than 10% for excessive 
straining and up to 20% in nursing homes 1. The overall incidence of 
constipation in adults in the Western world is estimated at 15% 2. 
The most common causes for chronic constipation are general causes like 
low fibre diet, low fluid intake and physical inactivity 3-6.  Medication 
(anticholinergic, antidepressants, opioid analgetics, NSAID) 7, neurological 
and psychiatric disorders and idiopathic chronic constipation are other 
common causes 8. There are also socioeconomic, sex, regional and 
national differences in prevalence of constipation 9,10. Constipation 
significantly impairs health-related quality of life and only 66% of the 
patients consider their treatment as sufficient 11. Functional constipation is 
defined according to the Rome III criteria, were both slow transit and 
difficult evacuation are considered 12.  
Mild constipation can be managed with non-pharmacological intervention 
like fibre-enriched diet which increases faecal bulk, increased fluid intake 
(>2 litters) and a more active lifestyle. Further physiotherapy, biofeedback 
and yogic breathing can be helpful in relaxing the pelvic floor and thus 
promoting defecation and evacuation. More severe constipation requires 
treatment with laxatives. There are several types of laxatives: bulk-forming, 
osmotic and stimulant 13. Bulking agents include methylcellulose, psyllium 
and polyethylene glycol. 
Patients suffering from severe chronic functional constipation require a long-
term, regular therapy with laxatives. Although the literature is very scarce on 
this subject we know that the taste of laxatives is often not appreciated by 
patients 14,15.  Many patients find it difficult to deal with poor tasting 
medication when prescribed. This counts especially for geriatric and 
paediatric patients with chronicle medication use. Such problems result in 
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high incidence of non-compliance which is one of the leading reasons of 
therapy failure 15,17. 
Polyethylene glycol based products (PEG) are iso-osmotic solutions, which 
are effective 18-21, safe 22-14 and increasingly used in chronic constipation in 
both adults and children. It has been suggested that the taste of PEG 4000 
was appreciated by the patients 15. 
The aim of the study was to compare the taste of two commonly used 
polyethylene glycol preparations, PEG 4000 (Forlax®) and PEG 3350 
(Movicolon®).  
Methods 
Study design 
A total of 100 healthy volunteers recruited by advertisement were included 
in a double blind, randomized cross over study. All volunteers were invited 
to taste both preparations. After tasting the first 25ml without swallowing, 
the mouth was rinsed and the second preparation was tasted without 
swallowing. Then a score on a 5-point scale was given (1=very bad taste, 
5=very good taste) for both preparations. It was investigator initiated study. 
Permission nr 06/081 was granted from the central medical ethics review 
board of the VU University Medical Centre.  
Polyethylene glycol preparations 
PEG 4000 (Forlax®) consists of 10g macrogol 4000 per sachet, is an orange-
grapefruit flavoured, gentle acting osmotic laxative. It contains no extra salt 
and electrolytes. It is neither absorbed nor metabolized. PEG 3350 
(Movicolon®) contains 13.125g macrogol 3350, sodium hydroxide 
carbonate 178.5mg, sodium chloride 350.7mg, potassium chloride 46.6mg 
and citron aroma. The extra electrolytes cause taste of this laxative.  
Each dosis of the preparations was dissolved in 150 ml of cold water 
conform the instructions.   
Statistics  
All results were analyzed in Wilcoxon matched pairs test (GraphPad InStat 
Software, SanDiego, Ca, USA). 
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RESULTS 
All 100 volunteers were included (27 males and 73 females, mean age 36, 
range 18-65). Eighty-four volunteers preferred the taste of PEG 4000, 9 found 
no differences in taste between the two preparations and only 7 preferred 
the taste of PEG 3350. The taste score for PEG 4000 (mean 3.9, median 4, SD 
0.7) was significantly better than PEG 3350 (mean 2.7, median 3, SD 0.7) 
(p<0.0001) (Figure 1). There was no difference in gender or age observed.  
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Figure 1. Taste scores (1=very poor taste, 5=very good taste) for PEG 4000 
and PEG 3350 given by the volunteers (p<0.0001). 
 
 
The volunteers who tasted PEG 3350 first appreciated the taste significantly 
more than persons which tasted it second (p<0.0001). The order in which 
volunteers tested PEG 4000 had no influence on the taste results of this 
preparation  
(Table 1). 
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scores PEG 4000   
first tried 
PEG 4000   
second tried 
PEG 3350  
first tried 
PEG 3350  
second tried 
1 0 1 0 2 
2 0 2 5 39 
3 9 9 32 8 
4 34 31 13 1 
5 7 7 0 0 
mean 3.96  3.82  3.16  2.16  
p 0.3161                      0.3161                      <0.0001               <0.0001 
   
Table 1. Taste scores according to the sequence of tasting of the PEG 
solutions.  
 
DISCUSSION 
This study showed that PEG 4000 tastes better in comparison to PEG 3350, 
independent of gender or age. In addition, PEG 3350 was even less 
appreciated when PEG 4000 was tasted first. The sequence of tasting did 
not differ for PEG 4000.  In spite of rinsing the mouth, the PEG 3350 was 
overall less appreciated.  
Causes of non-compliance in long-term medical treatment are the 
medications´ taste and dosage frequency. It would be helpful to switch to 
another better tasting preparation when patients dislike the taste. However, 
this study has only demonstrated a preference for PEG 4000 during a single 
intake of 25 ml of fluid. Weather this difference is so outspoken after months 
or years is unknown. We chose for this method without swallowing since 
taste was the issue and not the volume load; the volume of PEG as a 
laxative is only 150-300 ml daily. The odour of the preparation may also 
influence the judgement of the volunteers. 
We could expect however that PEG 4000 should be more appreciated by 
the patients and as a result may be more effective in long-term treatment. 
At the other hand, mixing with other fluids might also compensate for poor 
taste. 
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In conclusion, the taste of PEG 4000 is generally more appreciated then the 
taste of PEG 3350. When patients complain about the taste of their PEG 
preparation switching may be an alternative. 
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Summary and conclusions 
The aim of the work in this thesis was to study the epidemiology, diagnostic 
procedures and therapy of anorectal and colorectal diseases. Several 
topics were studied to approach this goal. Some studies analyzed 
acceptability and tolerability of the investigations and treatments, since 
patient compliance is important for a successful result.  
 
Anorectal complaints are debilitating and form a frustrating problem for 
both patients and their doctors. Patients are often referred for anorectal 
function evaluation (AFE). The aim of the study in chapter 2 was to 
determine which referrals of the patients with anorectal symptoms for AFE 
were indicated to establish a diagnosis with subsequent therapeutic 
consequences. In a retrospective study from 216 referred patients, only 65% 
of referrals were indicated. AFE has therapeutic consequences for some 
diagnoses like in faecal incontinence without diarrhea, 3rd degree sphincter 
rupture, pre-operative for stoma or re-anastomosis, fistula, fissures and 
sometimes constipation. Anal ultrasound is always indicated in patients with 
fistula, manometry and rectal compliance only when impaired continence 
reserve is suspected. In 80% the advice was followed: in 35% of the patients 
the complains were improved and 57% of the patients was reassured. The 
effect of advices was also studied and consisted of dietary, physiotherapy, 
medications and surgery. On a VAS scale (1 to10) complains improved an 
average of 3.2 points. Most patients tolerated AFE very well and perceived 
minimal discomfort during AFE. It is important to provide better information 
for referring doctors about diagnostic possibilities of the AFE to ensure the 
most optimal advantage of indicated referrals.  
 
Therapy for faecal incontinence remains a difficult issue and is often 
inadequate. Temperature–controlled radiofrequency energy (SECCA) is a 
therapy with favorable results in few open studies. In chapter 3 we report 
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the promising results of this relatively new therapeutic method. The mode of 
action of this treatment seems to be the increased rectal sensitivity.  
We treated 11 women with long existing faecal incontinence complains.  
In three months time, 6 of them improved and this improvement persisted 
during the follow-up of 1 year. Anal manometry and rectal compliance 
showed no significant changes between those who improved and those 
who did not. The treatment was well tolerated and side effects such as 
local haematoma, minor bleeding, pain persisting 1-3 weeks and laxatives-
related diarrhea during 1-3 weeks were acceptable. However, more 
investigations and placebo-controlled studies are warranted with a larger 
number of patients and longer follow-up.  
 
Irritable bowel syndrome (IBS) is an invaliding common functional disorder. 
IBS has a wide range of symptoms, though specific symptoms are lacking. In 
this way IBS can easily mimic other diseases in the (lower) abdomen, thus 
causing delay in establishing the right diagnosis and giving the appropriate 
treatment. We have studied these difficulties in chapter 4. Hundred and one 
patients with proven endometriosis were included from the gynecological 
outpatients clinic. By means of a questionnaire patients who complied with 
Rome III criteria were referred to our gastroenterological outpatient clinic. 
Fifteen percent of the patients had additional IBS and 14% had functional 
constipation without IBS. Of the 22 patients finally presented to the 
gastroenterologist, 5 had a significant stenotic rectosigmoid and underwent 
surgical resection of the involved bowel segment with primary anastomosis. 
Four of the operated patients improved clinically and had no symptoms, 
the fifth had a stenotic anastomosis and was successfully dilated. The 
remaining 17 patients were treated conservatively with laxatives and fiber. 
Defecation symptoms improved in 86% and pain was reduced in 64%. For 
many women with endometriosis and additional IBS or chronic constipation 
good cooperation between gynecologist and gastroenterologist is essential 
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and can give symptom relief in a shorter time. However, for many women 
with endometriosis management of pain is still insufficient. 
 
The prevalence of diverticulosis and subsequently diverticulitis is increasing 
the last decades. Diverticulosis increases with age. It is estimated less than 
10% in those under the age of 40 and increases to 65-70% in those above 65 
years of age.  Therefore, diverticulitis is also increasing. Predominant western 
lifestyle increases this pathology, with all their complications and 
consequences. In chapter 5 we review the literature concerning the 
pathogenesis, prevalence, diagnostic procedures and therapeutic options 
of diverticulitis.  
 
In the literature the relationship between diverticular disease and colorectal 
cancer has been suggested. Considering the increasing prevalence of 
diverticular disease and incidence of colorectal cancer in younger 
patients, this might have consequences for colorectal cancer surveillance. 
In chapter 6 we studied the possible risk for colorectal neoplasia or polyps in 
4,241 colonoscopies of patients with diverticulosis and diverticulitis. 
Diverticula, diverticulitis, and polyps were found in 25%, 2% and 30% of the 
colonoscopies, respectively. However, no association was found between 
patients with polyps and those with or without diverticulosis. Colorectal 
cancer was found in 9% of the patients. We observed a negative relation 
between diverticulosis and colorectal cancer and invasive 
adenocarcinoma. We could not find any association between polyps, 
diverticulosis or diverticulitis and increased risk for colorectal cancer. A 
drawback of the study was the underreporting of polyps and their possible 
earlier removal as well as the lack of long term follow-up. 
 
In chapter 7 the relationship between diverticulitis and colorectal 
carcinoma was studied in a retrospective, longitudinal study. In 288 patients 
the colonoscopies and pathology registry PALGA of the patients admitted 
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to our hospital with diverticulitis were analyzed. Colorectal cancer and 
colonic adenomas were detected in 1,7% and 6,3% of the patients, 
respectively. However, again this study showed a lower prevalence of 
colorectal cancer and colonic adenomas in patients with diverticulosis.  
Underreporting is possible due to the retrospective character. More 
attention and further prospective, longitudinal studies are warranted about 
this subject. So far, a strong relationship does not seem likely. 
 
Patient compliance is an important factor for successful establishing a 
diagnosis or following a therapy. Colonoscopy is still the most important tool 
in screening and surveillance programs of patients with colorectal disease. 
Adequate preparation of the colon is important for good quality and safety 
of the examination. Chapter 8 refers to a prospective, randomized study 
comparing the effectiveness of two preparation in 110 patients referred for 
elective colonoscopy with 3 litre sulphate-free polyethylene glycol solution 
(SF-PEG) or 4 litre PEG. Data was analyzed with respect to stool frequency, 
medication, concomitant diseases and diverticular disease diagnosed 
during the investigation. No differences were found between two regimes 
of preparation in cleansing the rectosigmoid or complete colon. Moreover 
diverticulosis and constipation had no influence on quality of cleansing. 
Both preparations had comparable acceptability and tolerability of the 
colon cleansing, however patients preferred cleansing with a smaller 
volume of solution. This can improve the compliance of the patients and 
improve their acceptance for colonoscopy.  
 
Treatment of chronic constipation is not always easy and usually life-long. 
Laxatives often do not have an encouraging taste to use it for a long time. 
For this reason poor compliance and effectiveness of the treatment is only 
in 66% of patients sufficient. Chapter 9 describes a study, which compared 
the taste of two polyethylene glycol preparations for patients suffering from 
constipation. In a double blind, cross over, randomized trial 100 volunteers 
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tasted both preparations. They gave score on 5-point scale of taste. The 
taste score for PEG 4000 was significantly better than for PEG 3350. Whether 
this results in long-term better compliance for PEG 4000 can not be 
established from these data.   
 
Conclusions 
 
This thesis allows several conclusions on epidemiological, diagnostic and 
therapeutic field of anorectal and colorectal diseases.  
1. The anorectal function evaluation has therapeutic consequences 
only for some diagnoses. Good education and awareness of 
anorectal diseases is important for prompt treatment and / or 
indicated referral. 
2. Temperature–controlled radiofrequency energy can be a new 
therapy for faecal incontinence in the near future.  
3. In patients with endometriosis and in addition IBS or chronic 
constipation gastroenterological consult can contribute to better 
symptom relieve. The gynaecologist is also an important partner for 
the gastroenterologist. 
4. Diverticulosis and diverticulitis form no increased risk for colorectal 
cancer. 
5. Success in treatment depends on good compliance of the patients, 
so palatability and amount of volume intake are important issues. 
 
 
Implications 
 
More education in anorectal disorders is necessary and problem orientated 
pelvic floor units will be developed. 
New therapies for faecal incontinence will emerge, since none of the 
existing ones are adequate. SECCA may be one of them. This method has 
shown a promising effect in USA, where this treatment has already 5 years 
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follow-up and there are many new studies published. We have already 
started prospective, longitudinal, randomised study. 
Interest in diverticular disease and diverticulitis is growing, since the disease 
is so widespread and can have a (life) threatening course. More 
longitudinal, prospective studies are warranted concerning different 
aspects of diverticulitis. 
At last, patient compliance is a very important issue which will receive even 
more attention in the future. Not only taste, but also other life style issues will 
be introduced. 
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Samenvatting  
Het doel van de studies in dit proefschrift was de epidemiologie, 
diagnostiek en therapie van anorectale en colorectale aandoeningen te 
onderzoeken. Om dit doel te bereiken hebben wij een aantal onderwerpen 
bestudeerd. In enkele studies hebben wij de acceptatie door patiënten 
van de onderzoeken en behandelingen geanalyseerd, aangezien dit 
belangrijk is voor een succesvol resultaat.  
 
Anorectale klachten zijn buitengewoon hinderlijk en kunnen sociaal 
isolerend zijn. Zij vormen een bron van frustratie voor zowel patiënten als 
artsen. Veel patiënten worden verwezen voor anorectaal functie 
onderzoek (AFO). Het doel van de studie in hoofdstuk 2 was vast te stellen 
welke van de verwijzingen voor AFO van patiënten met anorectale 
klachten daadwerkelijk geïndiceerd zijn, teneinde een diagnose te kunnen 
stellen met vervolgens therapeutische consequenties.  
In een retrospectieve studie met 216 verwezen patiënten, waren slechts 
65% van de verwijzingen geïndiceerd. AFO heeft therapeutische 
consequenties voor een aantal diagnosen zoals faecale incontinentie 
zonder diarree, 3e graads sfincter ruptuur, preoperatief voor stoma of re-
anastomose, fistula, fissuren en sommige vormen van obstipatie. Anale 
endoechografie is altijd geïndiceerd bij patiënten met fistula. De 
manometrie en rectale compliantie zijn alleen geïndiceerd bij verdenking 
op een verminderde continentie reserve. Tachtig procent van de gegeven 
adviezen werden opgevolgd: bij 35% van de patiënten waren de klachten 
verbeterd en 57% van de patiënten waren tevreden. Het effect van de 
adviezen werd ook bestudeerd. De adviezen bestonden uit dieet, 
fysiotherapie, medicatie en/of chirurgie. Op de VAS schaal (1 tot 10) waren 
de klachten gemiddeld 3.2 punten verbeterd. De meeste patiënten 
hadden AFO goed verdragen en er was nauwelijks sprake van ongemak 
tijdens het onderzoek. Het verstrekken van betere informatie over de 
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diagnostische mogelijkheden van AFO is belangrijk voor verwijzende artsen 
teneinde geïndiceerde verwijzingen te garanderen.  
 
De behandeling van fecale incontinentie vormt een groot probleem en is 
vaak teleurstellend. Temperatuur-gecontroleerde radiofrequente energie 
(SECCA) is een behandeling met gunstige resultaten in een aantal open 
studies. In hoofdstuk 3 melden wij de veelbelovende resultaten van deze 
relatief nieuwe therapeutische methode. Een verhoogde rectale 
gevoeligheid lijkt het werkingsmechanisme van deze behandeling te zijn. Elf 
vrouwen met lang bestaande fecale incontinentie klachten werden 
behandeld. Drie maanden na de behandeling waren bij 6 patiënten de 
klachten verbeterd en dat effect hield aan gedurende de hele periode 
van de 1 jaar follow-up. Anale manometrie en rectale compliance lieten 
geen significante veranderingen zien tussen de verbeterden en zij die niet 
verbeterd waren. De behandeling werd zeer goed verdragen en enkele 
bijwerkingen (locaal hematoom, wat bloedverlies, lokale pijn met 
aanhoudende duur van 1-3 weken en laxantia gerelateerde diarree van 1 
tot 3 weken) waren acceptabel. Echter, verder onderzoek en placebo 
gecontroleerde studies met een groter aantal patiënten en langere follow-
up zijn nodig.  
 
Irritable bowel syndrome (IBS) is een invaliderende veel voorkomende 
functionele aandoening. IBS heeft een groot spectrum van symptomen, 
maar heel specifieke symptomen ontbreken. Hierdoor kan IBS heel 
gemakkelijk andere ziektes simuleren in de (onder)buik, en zo vertraging 
veroorzaken in de diagnostiek en juiste behandeling. Deze problemen 
hebben wij onderzocht in hoofdstuk 4. Van de polikliniek gynaecologie 
werden 101 patiënten met bewezen endometriose geincludeerd. Met 
behulp van vragenlijsten werden patiënten die voldeden aan de Rome III 
criteria voor IBS en/of obstipatie naar onze polikliniek maag-, darm- en 
leverziekten verwezen. Vijftien procent van de patiënten hadden IBS en 
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14% had functionele constipatie zonder IBS. Uiteindelijk werden 22 patiënten 
gezien door de maag-, darm- en leverarts. Vijf hadden een significante 
stenose in het rectosigmoid en ondergingen een chirurgische resectie met 
primaire anastomose. Vier van de geopereerde patiënten waren klinisch 
verbeterd en hadden geen klachten, de vijfde ontwikkelde een 
naadstenose en werd succesvol gedilateerd. De andere 17 patiënten 
werden conservatief behandeld met laxantia en vezels. De defecatie 
klachten verbeterden in 86% en de pijn verminderde in 64%. Goede 
samenwerking tussen gynaecoloog en maag-, darm- en leverarts is 
onmisbaar voor de vele vrouwen met endometriose en bijkomende IBS of 
chronische obstipatie. Dit kan verlichting geven van de klachten in kortere 
tijd. Echter, voor veel vrouwen met endometriose is behandeling van de 
pijn nog steeds onvoldoende.    
 
De prevalentie van diverticulose is de laatste decennia gestegen. 
Diverticulose neemt toe met de leeftijd en wordt geschat op minder dan 
10% onder de 40 jaar en neemt bij toe bij 65 plussers tot 60-70%. Hierdoor 
neemt de prevalentie van diverticulitis ook toe. Een predominant westerse 
levensstijl verhoogt het risico voor deze pathologie, met al zijn complicaties 
en gevolgen. Hoofdstuk 5 geeft een literatuuroverzicht betreffende 
pathogenese, prevalentie, diagnostiek en therapeutische mogelijkheden.  
 
In de literatuur wordt een relatie tussen diverticulose/diverticulitis en 
colorectaal carcinoom gesuggereerd. Gezien de stijgende prevalentie ook 
bij jongere mensen kan dat consequenties hebben voor surveillance. In 
hoofdstuk 6 hebben wij het mogelijke risico onderzocht voor colorectaal 
carcinoom of poliepen in 4241 colonoscopieën bij patiënten met 
diverticulose en/of diverticulitis. Divertikels, diverticulitis en poliepen werden 
respectievelijk in 25%, 2% en 30% van de colonoscopieën gevonden.  
Er werd geen associatie tussen patiënten met poliepen en aan afwezigheid 
van diverticulose gevonden. Colorectaal carcinoom werd bij 9% van de 
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patiënten gevonden. We zagen een negatieve correlatie tussen 
diverticulose met colorectaal carcinoom en met invasief adenocarcinoom. 
Wij konden geen associatie vinden tussen poliepen, diverticulose of 
diverticulitis en een verhoogde risico voor colorectaal carcinoom. Een 
nadeel van de studie was zowel de onderreportage van poliepen als 
mogelijke eerdere verwijdering hiervan, naast een onvoldoende lange 
follow-up.  
 
In hoofdstuk 7 werd de relatie tussen diverticulitis en colorectaal carcinoom 
in een retrospectieve, longitudinale studie onderzocht. De colonoscopie 
verslagen en het pathologie register PALGA van 288 patiënten die 
opgenomen waren in het ziekenhuis wegens diverticulitis werden 
geanalyseerd. Colorectaal carcinoom en adenomen van het colon 
werden respectievelijk in 1.7% en 6.3% van de patiënten gevonden. Echter, 
ook deze studie liet een lagere prevalentie zien van colorectaal carcinoom 
en adenomen in patiënten met diverticulitis.  
Onderreportage is mogelijk gezien het retrospectieve karakter van de 
studie. Meer aandacht en verdere prospectieve, longitudinale studies zijn 
nodig. Tot nu toe lijkt een sterk verband tussen diverticulitis en colorectaal 
carcinoom niet aanwezig.  
 
Goede medewerking van de patiënten is een belangrijke factor voor 
succesvolle diagnostiek en behandeling. De colonoscopie is het 
voornaamste instrument in screening en surveillance programma’s voor 
patiënten met colorectale aandoeningen. Adequate voorbereiding van 
het colon voor een goede kwaliteit en veiligheid van het onderzoek is 
belangrijk. Hoofdstuk 8 betreft een prospectieve, gerandomiseerde studie, 
die de effectiviteit van twee preparaten vergelijkt, 3 liter sulfaat-vrij 
polyethyleen glycol en 4 liter polyethyleen glycol, bij 110 patiënten 
verwezen voor electieve colonoscopie. De data werden geanalyseerd met 
betrekking tot defecatie frequentie, medicaties, andere ziekten en 
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diverticulose gediagnosticeerd tijdens de colonoscopie. Er werd geen 
verschil in kwaliteit van voorbereiding van rectosigmoid of colon gevonden 
tussen beide schema’s. Bovendien hadden diverticulose en obstipatie geen 
invloed op de kwaliteit van de voorbereiding. Beide preparaten waren 
vergelijkbaar qua acceptatie en tolerantie voor colon voorbereiding, 
hoewel patiënten de voorkeur hadden voor voorbereiding met een 
kleinere hoeveelheid vloeistof. Dit kan de compliantie en acceptatie van 
de patiënten voor colonoscopie verbeteren.  
 
De behandeling van chronisch obstipatie is niet altijd gemakkelijk en 
meestal levenslang. De smaak van laxantia nodigt meestal niet uit tot 
langdurig gebruik. Dit is een reden van lage compliantie en waardoor de 
effectiviteit van behandeling slechts in 66% effectief is. Hoofdstuk 9  
beschrijft een studie die de smaak vergelijkt van twee polyethyleen glycol 
(PEG) preparaten voor patiënten met obstipatie. In de dubbel-blind, cross 
over, gerandomiseerde studie proefden 100 vrijwilligers beide preparaten. 
De smaak-scores werden op een 5-punts schaal aangegeven. De smaak-
score voor PEG 4000 was significant beter dan voor PEG 3350. Of deze 
resultaten op langere termijn zorgen voor een betere compliantie 
betreffende PEG 4000, kan met deze data niet beoordeeld worden.  
 
Conclusies 
Uit dit proefschrift kunnen enkele conclusies getrokken worden betreffende 
epidemiologie, diagnostiek en therapie van anorectale en colorectale 
aandoeningen. 
1. Anorectaal functie onderzoek heeft alleen therapeutische 
consequenties voor sommige diagnosen. Goede educatie en kennis 
van anorectale aandoeningen is belangrijk voor de juiste 
behandeling en/of geïndiceerde verwijzing.  
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2. Temperatuur gecontroleerde radiofrequente energie (SECCA) kan 
in de nabije toekomst een nieuwe therapie vormen voor fecale 
incontinentie.  
3. Bij patiënten met endometriose en IBS of chronische obstipatie kan 
een consult bij de maag-,darm-, en leverarts in een verbetering van 
de klachten resulteren.  
4. Diverticulose en diverticulitis vormen geen risico voor colorectaal 
carcinoom. 
5. Succes van behandeling is afhankelijk van goede compliantie van 
patiënten;  zowel smaak als volume van de medicatie zijn belangrijk.  
 
Implicaties 
Meer educatie over anorectale aandoeningen is noodzakelijk en probleem 
gerichte bekkenbodemcentra zullen verder ontwikkeld worden. 
Nieuwe therapeutische opties voor fecale incontinentie nemen toe, daar 
geen van bestaande behandelingen echt voldoende zijn. SECCA kan een 
van die opties zijn. Deze methode liet positieve effecten zien in de VS, waar 
deze behandeling al 5 jaar follow-up heeft en enkele nieuwe studies 
gepubliceerd zijn. Wij zijn al begonnen met een longitudinale, prospectieve, 
gerandomiseerde studie.   
Interesse in diverticulose en diverticulitis neemt toe, aangezien deze ziekte 
vaak voorkomt en een (levens)bedreigend beloop kan hebben. Meer 
longitudinale, prospectieve studies zijn nodig met betrekking tot 
verschillende aspecten van diverticulitis.  
Tenslotte is de compliantie van de patiënten een heel belangrijk punt en zal 
in de toekomst nog meer aandacht krijgen. Niet alleen smaak en 
hoeveelheid, maar ook andere levensstijl aspecten zullen een rol spelen bij 
diagnostiek en therapie. 
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